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Extensive work has been done on virus pneumonia of pigs (VPP) 
or swine enzootic pneumonia (SEP) as to its pathology, transmission 
and significance. However, only after the demonstration that the 
etiological agent was a mycoplasma did the research on this subject 
begin to make meaningful progress. 
Since the etiological agent is a mycoplasma, the term VPP 
has been abandoned in favor of the more explicit name, mycoplasma 
pneumonia of swine or MPS. The agent, which has been named Myco­
plasma hyopneumoniae, is a small, cocco-bacillary, filtrable and 
weakly Gram negative staining organism, capable of growing in cell-
free medium. 
This present study was focused on the immunologic responses 
elicited by M. hyopneumoniae in its host, the pig. It includes 
serologic response of pigs to Mycoplasma hyopneumoniae infections, 
serologic diagnosis of MPS, and active and passive immunization 
against the disease. 
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LITERATURE REVIEW 
This literature review is composed of four parts; 1) Myco­
plasma hyopneumoniae pneumonia of pigs; 2) serologic tests em­
ployed for the diagnosis or identification of non-swine myco­
plasmal diseases or mycoplasmas; 3) serologic tests employed in 
the diagnosis or identification of swine mycoplasmal diseases or 
swine mycoplasmas; 4) mycoplasma vaccines and vaccination pro­
cedures currently used for immunization against mycoplasma infections. 
Mycoplasma hyopneumonia Pneumonia of Pigs 
Mycoplasma hyopneumoniae is the causative agent of a wide 
spread swine pneumonia sometimes referred to as swine enzootic 
pneumonia (SEP) or virus pneumonia of pigs (VPP). The causative 
agent was isolated, characterized, propagated and named by Mare and Swit-
zer (1965). The size of the organism is estimated to be between 
110 mu and 225 mu in diameter. Observation of Giemsa stained prep­
aration revealed coccoid to cocco-bacillary bodies with occasional 
ring forms. Cultures of organism grown in cell-free medium were 
capable of producing pneumonia in 80 to 100 per cent of the inoc­
ulated pigs (Mare, 1965). Goodwin et al. (1965) were also able to 
grow a mycoplasma from their J strain of enzootic pneumonia. The 
name M. suipneumoniae was given to this isolate (Goodwin et al^. 1967). 
The cultures of M. hyopneumoniae and M. suipneumoniae were indistin­
guishable by the growth inhibition and metabolic inhibition test. 
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according to the same authors. The specific name of M. hyo-
pneumoniae thus has priority and unless it can be shown to be a 
nomen dubium, M. suipneumoniae must be regarded as a later homonym 
(Edward and Freundt, 1969). 
Details of history, incidence, pathology, and transmission 
of mycoplasmal pneumonia have been reviewed by Mare (1965 and 1969) 
and by Switzer (1969). Briefly, the MPS is spread from one pig 
to another by direct contact. Young pigs usually contract MPS 
from their mothers (Young, 1964). The prevalence of MPS has been 
estimated to vary from 34 to 74 per cent (Young artd Underdahl, 
1955; Betts 1952; Young and Underdahl, 1960). HoWever, there are 
several agents that can result in grossly similar lesions (Pattison, 
1956; Jericho, 1968). Caution must therefore be used in the 
evaluation of the incidence of MPS and economic effect on gross 
pathology alone. 
The macroscopic lesions of mycoplasmal pneumonia are found 
predominantly in the apical, cardiac and intermediate lobes of the 
lung. It is characterized by clearly demarcated, reddish-blue 
to light pinkish-grey colored lesions in those lobes. Microscopic 
lesions consist of alveolar interstitial thickening, 
giant cell formation, neutrophil infiltration, septal cell proli­
feration, and peribronchiolar and perivascular lymphoid hyper­
plasia (Mare 1965). i 
There were no definitive diagnostic aids until recent develop­
ment of complement-fixâtion test (Roberts 1968; Takatori et al. 1968; 
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Boulanger and l/Ecuyer 1968; and llodyi^s aj_- 1969). There is no 
effective treatment for MPS. 
Serologic Tests Employed for the Diagnosis or Identifi­
cation of Non-swine Mycoplasmal Diseases or Mycoplasmas 
Immunofluorescence 
Liu (1957) demonstrated the causative agent of human pri­
mary atypical pneumonia (the Eaton agent) in the bronchial 
epithelium of chicken embryos by using direct immunofluorescence 
(IMF). The agent was found to multiply exclusively in the cyto-
plasma of the bronchiolar and air-sac lining epithelium. Marmion 
and Goodburn (1961) used IMF to stain infected chicken embryo 
lungs and found that the infectious particles were minute cocco-
bacillary bodies resembling mycoplasma. Proof that the fluorescent 
staining cocco-bacillary bodies were indeed mycoplasma was provided 
by growth of the agent on cell-free medium and its characterization 
(Chanock e^ al^. 1962). The name Mycoplasma pneumoniae was given to 
the agent. 
Clark e^ al. (1963) used IMF in their study of Mycoplasma 
hominis ând found that specific fluorescent staining was a suitable 
procedure for identification of the mycoplasma. The antigens of 
this mycoplasma as revealed by IMF were found to remain in the in­
soluble residue (cell membrane fraction) after exposure of M. 
hominis to sonic vibration for 30 minutes followed by centrifuga-
tion. Immunofluorescence had also been used for the demonstration 
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of mycoplasma contamination in cell cultures. Carski and Shepard 1961 
showed that inoculated mycoplasma randomly distributed over tissue cul­
ture monolayer preparations. And later Malizia (£t ^.(1961), also used 
IMF in their study of tissue culture origin mycoplasma. However, 
these two groups of investigators presented completely opposite 
interpretation as to the localization of mycoplasma in tissue culture 
cells. The former group found the organisms on the cell membrane and 
in inter-cellular spaces, whereas the latter group found them to be 
intracytoplasmic. 
In spite of the specificity the IMF has, the technique has not 
enjoyed wide application due to the laborious preparations required. 
However, Del Giudice e^ (1967) described a direct IMF for rapid 
identification of mycoplasma colonies growing on agar plates that elim­
inated subculturing the organism and greatly reduced the time needed for 
identification. The procedure was shown to be effective for detection 
of mixtures of mycoplasma serotypes on primary isolation plates. 
Immunofluorescence has also been used for the identification of M. 
pneumoniae in direct smears of sputum (Hers and Masurel, 1967), how­
ever, the applicability of this technique was limited. 
Masiga and Stone (1968) applied IMF to the study of Mycoplasma 
mycoldes. They found it to be a specific identification technique 
as evaluated by four criteria: 1) fluorescence was not observed 
with M. agalactiae, M. mycoides var. capri and M. bovigenitalium; 
2) fluorescence could be eliminated by adsorption of the antiserum 
with M. mycoides; 3) fluorescence was not observed in non-inoculated 
broth smears; and 4) contagious bovine pleuropneumonia Immune sera 
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inhibited the IMF reaction. 
Immunefluorescent staining of Eaton agent infected chicken 
embryo lungs by human convalescent serum was markedly enhanced by 
heat-labile substances in fresh human serum and guinea pig serum 
(Liu 1961). However, subsequent findings of Lind (1965) indicated 
that a diminution of fluorescent staining sometimes occurred when 
fresh guinea pig serum was added to human convalescent serum and 
that the enhancement effect was partially dependent upon the source 
of conjugated antiglobulin employed. 
Complement fixation 
Both hemolytic and conglutinating complement fixation (CF) 
tests had been tried by various workers for the diagnosis of con­
tagious bovine pleuropneumonia (CBPP) (Heslop 1921, 1922; Walker 
1922). Most of these workers had difficulties with the test. The 
first satisfactory method was that of Campbell and Turner (1936). 
This test has been widely used and is still regarded as the best 
single test tor the diagnosis of CBPP. 
Chanock et a]^. (1962a and b) successfully propagated the Eaton 
agent in a broth medium and identified it as a mycoplasma. They 
prepared a phenol-treated CF antigen from cultures of the organism 
and found that although CF was less sensitive than IMF, both tests 
yielded similar results with paired sera from persons with atypical 
pneumonia. Taylor-Robinson eit (1963) used the CF test to study 
the. antigenic relationships of mycoplasmas. The CF test when compared 
with IMF and indirect hemagglutination test, was found to be 
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the least sensitive, i. e., antibody titers were the lowest (Taylor-
Robinson £t £l. 1966b). Til is may account for the fact that the CF 
test detected 85 per cent of the M. pneumoniae infection that were 
diagnosed by other serological techniques in their study. 
Gamble (1956) noted that killed M. mycoides inoculated into 
experimental animals would not produce CF antibodies and proposed 
that CF antibodies were formed in response to metabolic products 
of living and actively metabolizing organisms. The antigens present 
in M. pneumoniae that react in the CF test are believed to be lipid 
in nature since they can be extracted by chloroform or ether (Kenny 
and Grayston 1965; Sobeslavsky £t £l. 1966; Marmion al. 1967; 
Beckman and Kenny 1968). Satisfactory boiled CF antigen has also 
been demonstrated by Lemcke (1965) from the CBPP organism. Some 
loss of CF activity after boiling has been noted. The heat stable 
CF antigen was located in lipid extracts of concentrated suspensions. 
The major heat stable CF antigens of M. pulmonis were water soluble 
and were probably protein or protein complexes (Deeb 1967 a and b). 
The M. pneumoniae CF antibodies in sera were present entirely 
or in part as 19s gamma-globulin (Schmidt et al. 1966) since the 
antibody activity was destroyed by treatment with mercaptoehhanol 
and by collection of blood onto filter paper discs. The anti­
body was capable of passing the placental barrier and was detect­
able at low levels in the sera of newborn infants (Weiser et al. 
1967). 
The CF test has had limited use in the study of avian myco­
plasmosis. Gianforte et. (1955) employed the CF test to 
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establish the identity of several isolates from various species, 
Lemcke (1964) used it for the differentiation of avian mycoplasma 
into 17 species and Frey and Hanson (1969) applied it to serotyping, 
assaying quantity of antigen produced in various media and for 
detecting mycoplasma antigen in infected tissues. 
Agglutination test 
Helsop (1922) used both microscopic and macroscopic ag­
glutination tests in the study of M. mycoides and found that both 
negative and positive sera agglutinated the antigen. He could 
demonstrate the presence of agglutinins in the serum of a hyper-
immunized calf and in the sera of animals naturally infected with 
CBPP, by the use of a macroscopic agglutination test. He believed 
that the macroscopic agglutination test was reliable and was simpler 
than the CF test to use as a mean of detecting the acute disease 
in live cattle. However, later workers (Yamagiwa e^ al. 1930; 
Campbell 1938) obtained disappointing results with the agglutination 
test especially with sera from chronic cases. Yamagiwa et_ al_. (1930) 
found strong agglutination reaction frequently occurred with sera 
from normal cattle. 
Klienberger (1938) studied mycoplasma antigens by means of 
the agglutination test. She classified 16 strains into 7 different 
serologic types. Norman £t a]^. (1950) found a marked antigenic 
similarity between five strains of human mycoplasma studied by the 
agglutination test. They observed that the homologous and hetero­
logous sera agglutinated mycoplasma at the same dilution or differed 
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in titer by only one or two dilutions, 
Priestley (1951) utilized the method of Campbell (1938) to 
devise a slide flocculation test for the diagnosis of CBPP. The 
so called wet method of the test consisted of mixing antigen and 
serum on a slide and waiting for flocculation to occur. The dry 
method consisted of placing a loopfull of serum on a slide and 
allowing it to dry in the air. The dried serum was re-dissolved 
in two loopfulls of concentrated antigen. The test was believed 
to be a satisfactory method of serodiagnosis and was believed to 
be more sensitive than CF. 
Newing and Field (1953) further simplified the preparation of 
the tests developed by Campbell and Priestley. They used stained 
antigen and whole blood from infected cattle for the test. This 
simplified test was found as satisfactory as the GF test. Ag­
glutinin persisted in the blood of vaccinated animals for some 
time after CF antibodies had disappeared. Further, it was con­
cluded, on the basis of CF and agglutination test results obtained, 
that the routine CF test could be replaced by the agglutination 
test. The latter test being more practical under field condition 
was less subject to erroneous interpretations (Newing and MacLeod 1955). 
An agglutination test antigen for testing chicken sera for 
M. galllsepticum antibodies was developed by Jungherr et al. (1956) 
but the antigen was less reliable in detecting agglutinin in turkey 
sera. Adler and Yamamoto (1956) developed an agglutination test 
! 
antigen which was adequate for detecting M. galllsepticum antibodies 
in turkey sera. Dlerks et al. (1967) used the agglutination test 
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to characterize avian mycoplasma. It was found that antigen made 
from organisms grown in medium enriched with dextrose was less 
sensitive in slide agglutination tests (Adler and DaMassa 1968). 
The agglutination test has also been used to study the antigens 
of mycoplasma from human and tissue culture sources (Bailey et_ al. 
1961; Tally 1963). Kerr al. (1964) found that macroscopic ag­
glutination occurred on a glass slide between one to three minutes 
after mixing one loopfull of serum and two drops of sonicated antigen. 
They tested acute and convalescent primary atypical pneumonia sera 
against M. pneumoniae and other mycoplasma. Convalescent sera and 
reference rabbit M. pneumoniae antiserum agglutinated only the M. 
pneumoniae antigen while one antiserum of avian origin weakly ag­
glutinated the M. pneumoniae antigen. It appeared that mycoplasma 
of different origin shared some similar antigen as revealed by ag­
glutination studies. 
Latex agglutination 
Latex particles are a colloidal suspension of hydrophilic 
particles. The stability of the suspension is maintained through 
the presence of a surface active agent (Alfrey 1954). Even so, the 
latex particles are in a comparatively unstable suspension. The 
addition of a small amount of proteins (10 ug/ml of latex) will cause 
the latex particles to flocculate. Large amounts of protein in­
crease the particle stability. This is the typical protective ef­
fects of a hydrophilic colloid on a hydrophobic one. As small 
amounts of protein are adsorbed, the initial surface on the latex 
particle is neutralized, causing instability. Upon further addition 
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of protein, the particles acquire a net charged surface due to 
the adsorbed protein and are thereby stabilized (Singer et al. 
1961)- The adsorption can be described by a Langmuir adsorp­
tion equation and by the mass action law. It can be expressed as: 
X = KN-Kr 
a 
where r is the amount of protein adsorbed; a is the equilibrium 
amount of protein remaining in solution; N is the maximum amount 
that can be adsorbed, and K is a binding constant. 
The adsorption process is in two steps. The amount of protein 
adsorbed in the first step is proportional to the latex particles, 
and a second step is a second layer of protein coat which contains 
about half the amount of adsorbed protein present in the first layer. 
The adsorbed proteins form a random immobile film with the molecules 
oriented parallel to the particle surface. Further adsorption of 
the second layer of protein coat thus takes place in the inter­
stices between molecules already coated, but now the molecules are 
perpendicularly oriented to the particle surface (Oresk.es and Singer, 
1961). 
Latex particles with their surface coated with proteins of 
various kinds can be agglutinated by specific antiserum (Christian 
et al. 1958; Carlisle and Saslaw^.]ggg; Oreskes and Singer, 
1961). Mycoplasma cells of human, avian, swine, goat, and tissue 
culture origins were able to adsorb to the latex particle and thus 
could be agglutinated bj Immune sera (Morton 1966). This adsorp­
tion was demonstrated by electron microscopy. 
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In sera from rabbit undergoing immunization with mycoplasam 
antigen, the presence of anti-mycoplasma antibodies were detected 
much sooner in the mycoplasma latex agglutination reaction test 
than in the agar-gel diffusion reaction or the growth inhibition 
tests (Morton, 1966). The sera oC guinea pigs and monkeys 
rcacted in a speciCic fashion wlieroas rabbit serum requires pro-
treatment to eliminate its non-specific agglutinin. Human sera 
given such pre-treatment still contain a non-specific agglutinin 
(Kende 1969). The use ot carbohydrate-free mycoplasma antigen as 
described by Morton and Roberts (cited by Kende 1969) could not 
remove these non-specific reactions. 
Growth inhibition test 
Inhibition of the growth of mycoplasma in a liquid medium 
by immune serum was first demonstrated by Priestley (1952) who 
used Mycoplasma mycoides and fresh convalescent blood from cattle 
infected with the organism. Subsequently, immune inhibition of 
M. hominls was demonstrated by incubating this organism with dilu­
tions of antiserum for various lengths of time, and then sub-
culturing the mixture in nutrient broth or on agar medium (Edward 
and Fitzgerald 1954). After an appropriate period of growth, the 
agar medium was examined for mycoplasma colonies. It was found 
that 1) irreversible inhibition of M. homonis by immune serum re­
quired 6 to 48 hours of exposure to the serum , 2) such inhibition 
occurred more rapidly with higher dilutions of antiserum at 37 C 
than at room temperature, and 3) inhibition of mycoplasma growth 
13 
in broth medium by immune serum did not require a heat-labile 
accessory factor. 
Yamamoto and Adler (1958) incorporated specific antisera 
into broth and agar media to inhibit the growth of avian myco­
plasmas and obtained variable results. However, Edward and Kar-
narek (1960), Fabricant (1960), Kelton and Van Rockel (1963) and Dierks 
et al. (1967) have successfully demonstrated the growth inhibiting 
reactions with hyperimmune rabbit sera when it was incorporated 
into agar medium. They employed the reaction for serotyping and 
characterization of mycoplasmas of avian origin. The growth of 
Mycoplasma mycoides var. mycoides was also inhibited by immune 
serum from cattle which had recovered from infection with M. 
mycoides (Domermuth et £l. 1967); the inhibitory activity of immune 
serum was completely removed by adsorption with M. mycoides. 
Huijsmans-Evers and Ruys (1956) reported a method of inhibiting 
human genital mycoplasma on solid medium by application of antisera 
saturated paper discs. Clyde (1964) perfected the test, and Stanbridge 
and Hayflick (1967) further modified the test by drying antibody 
impregnated paper discs at 5 C. When stored at -20 C, these discs 
had been found to retain inhibiting activity for longer than seven 
months. Since the discs could be stored for longer period of time, 
the test had significant advantages over other tests. 
It was observed by Edward and Fitzgerald (1954) that a heat-
labile accessory factor was not required for the inhibition of 
mycoplasma growth in broth medium, however. Bailey et. a^. (1961) 
found that fresh serum had a potentiating effect for the inhibition 
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reactions. Riggs e_t a^. (1967) also stated that immunoglobulins 
G and M inhibited mycoplasma growth and that inhibition was greatly 
enhanced by a heat-labile component of fresh serum. The same 
observation on accessory factor effect of fresh serum has been 
obtained by others (Fernald e_t al^. 1967a; Taylor-Robinson et al. 
1966a). Yet, Domermuth and Gourlay (1967) found the presence or absence 
of complement produced no detectable change in the inhibiting capac­
ity of immune serum. 
The substance in antisera responsible for growth inhibition 
of mycoplasma was found to be associated with the water-soluble 
globulin fraction. The fraction of the globulin removed from sera 
by agglutinating antigens also inhibited growth of mycoplasma in 
a similar manner (Clyde 1964). Cottew (1963) suggested that 
the growth inhibiting antibody exerted its effect by agglutination. 
His suggestion was supported by the work of Davies and Hudson (1968) who 
observed that animals that did not develop any complement fixing 
antibody titer still developed a persistent weak agglutination 
reaction, and a concurrent low growth inhibition titer. The demon­
stration that growth inhibiting antibody was not connected with 
immunity led them to believe that resistance to contagious bovine 
pleuropneumonia did not involve circulating antibody but was more 
probably due to some form of cell mediated immunity (Davies and 
Hudson 1968). 
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Growth inhibition test for organisms producing acid 
Cell suspensions of Mycoplasma mycoides, the organism of bovine 
contagious pleuropneumonia have the ability to utilize glucose, 
fructose, and mannose. Glucose, pyruvate, lactate, and in the 
presence of catalase, glycerol are oxidized quantitatively to 
acetate and 002- Anaerobically, pyruvate underwent dismutation to 
acetate, lactate and CO2. Neither glucose nor glycerol were attacked 
anaerobically (Rodwell and Rodwell 1953), yet in spite of the inability 
to breakdown glucose under anaerobic condition, it was concluded that 
glucose oxidation in M. mycoides proceeded by way of the Embden-
Meyerhoff pathway (Rodwell and Rodwell 1954). A strain of Myco­
plasma laidlawii was found to have a hexose monophosphate shunt since 
glucose-6-phosphate dehydrogenase, ribose-5-phosphate isomerase and 
transketolase were demonstrated (Castrejon-Diaz et al. 1963). Van Der-
mack and Smith (1964) presented evidence for a citric cycle in myco­
plasma. Neimark and Pickett (1960), Gill (1962), and Edward (1950) also 
observed utilization of glusose by mycoplasma organisms. In the 
presence of an indicator such as phenol red, the oxidation of glu­
cose to the lactate or acetate would change the color of the broth 
medium to yellow. The decrease of pH and consequent color change of 
the indicator were associated with growth of the organisms. The 
above phenomenon were inhibited by the addition of specific anti­
serum (Taylor-Robinson et £l. 1966 b and c). It was also found that 
unheated horse serum was necessary for the specific inhibitory effect. 
Without it the effect was greatly reduced (Taylor-Robinson et al^. 1965). 
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They indicated that a heat-labile accessory factor present in horse 
or guinea pig serum was important for the demonstration of specific 
antibody activity. 
Growth inhibit ion test for organisms utilizing arginine 
The rapid utilization of arginine by mycoplasma was first 
described by Smith (1955) who demonstrated that strains of Myco­
plasma hominis caused disappearance of citrulline. He attributed 
this activity to a desimidation pathway in the organisms which 
yielded a mole of citrulline and a mole of ammonia for each mole 
of arginine utilized. A degradation pathway for citrulline was also 
described (Smith 1959): 
1. Arginine *• Citrulline + ammonia 
2. Citrulline + inorganic phosphate —* ornithine + 
carbamyl phosphate 
3. Carbamyl phosphate + ADP * ATP + amonia + COg 
Razin and Cohen (1963); Schimke and Barile (1963) and McCarty et al. 
(1964) all reported the same ammonia forming mechanism in mycoplasmas. 
Barile and Schimke (1963), used this mechanism as the basis for a 
chemical method for detecting contamination of cell cultures by myco­
plasma. They utilized the citrulline level in the medium as an indi­
cation of contamination. Purcell e^ al. (1966a) found that addition 
of specific antiserum to the medium would inhibit the ability of 
the arginine utilizing organisms to utilize arginine, and thus the 
alkaline shift produced by the metabolism of the organism was inhibited. 
f 
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A labile accessory factor present in unheated guinea pig serum 
potentiated the inhibitory effect of the antiserum. Further ; Purcell 
et al. (1966b) found that they could also use this test for measure­
ment of antibody to T strain of mycoplasma. It was used for de­
tecting antigenic differences among isolates belonging to the same 
species. The results were in good agreement with results of nucleic 
acid homology studies of mycoplasma relationships. It appeared that 
the serological difference measured by the test reflected basic 
genetic difference between species (Purcell e_t a_l. 1967). 
Growth inhibition test utilizing tetrazolium reduction 
Tetrazolium salts can be used as indicators of electron transfer. 
Compounds such as triphenyltetrazolium chloride (TPTC) are converted 
from a soluble, colorless salt to an insoluble formazan in reduced 
state. The reduction of TPTC is dependent on enzyme systems, more 
specifically, the dehydrogenases (Kun and Abood, 1949). The de­
hydrogenases system is coenzyme I or coenzyme II linked (Mattison 
£t 1947). Flavoproteins are also involved in the enzymatic 
reduction of TPTC (Kun 1951; Brodie and Gots 1951). That mycoplasma 
had the ability to reduce tetrazolium compounds was first discovered 
by Somerson and Morton (1953). They noted that broth culture of M. 
pneumoniae reduced TPTC to a red formazan. In the presence of 
specific antiserum the ability to reduce TPTC was inhibited (Jensen 
1964). 
Based on this obervatlon, Senterfit and Jensen (1966) devised a 
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method for measuring growth-inhibiting antibody by adding serially 
diluted antise:-:a to broth cultures and observing the inhibition 
of TPTC reduction. They concluded that the presence of antibody 
correlated well with the resistance to disease. 
Gel diffusion 
Kurotchkin (1937) reported that a substance active in the 
specific precipitating reaction was present in the serum of animals 
infected with contagious bovine pleuropneumonia, and that it could 
also be extracted from the affected lungs. It was suggested that 
the antigen extracted from cultures of Mycoplasma mycoides was a 
specific carbohydrate. The high specificity and sensitivity of the 
substance indicated the possibility of its use for diagnostic purposes, 
especially for the detection of chronic infections (Kurotchkin 1937). 
White (1958) observed a strong precipitin reaction when hyperimmune 
sera were tested with exudate or saline extract of a lung lesion 
while culture and extracts of the organism gave the same results. 
Sera from cattle dying of CBPP when tested against immune rabbit 
sera often gave one or two lines of precipitation demonstrating 
the presence of circulating antigens probably released from extensive 
lesions and exudates which contained a high concentration of 
diffusible antigen (White 1958). 
Gel diffusion has been used for the study of the serological 
relationship among mycoplasmas (Taylor-Robinson £t al^. 1963; Taylor-
Robinson et al. 1964; and Taylor-Robinson et al. 1965). Lemcke (1965) 
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studied 16 strains of mycoplasma previously determined to be dis­
tinct by CF and found that gel diffusion revealed each of the 16 
to have a consistent pattern of three to seven precipitin lines 
with its homologous antiserum. However, cross reactions did occur 
between some strains, especially with antiserum produced with the 
aid of an adjuvant. The appearance of cross reactions was at­
tributed to the sharing of certain antigenic components. Taylor-
Robinson ^  al. (19L5) found that M. pneumoniae antigen did not 
react in the gel diffusion test with antisera to the other human 
mycoplasma nor did M. pneumoniae antisera produce lines with anti­
gens prepared from the other human mycoplasma. In addition, there 
was no reduction in intensity and number of precipitin lines after 
absorption of M. pneumoniae antiserum with heterotypic mycoplasma 
antigen. These findings indicated that M. pneumoniae was anti-
genically distinct. 
Hemagglutination inhibition and hemadsorption inhibition 
It was observed by Van Herick and Eaton (1945) that a myco­
plasma isolated from hen's egg agglutinated erythrocytes. Sub­
sequently a hemagglutination inhibition test for a naturally occur­
ring mycoplasma infection of poultry air saculitis was described 
based on the phenomenon (Jungherr et^ al^. 1953) that the addition of 
antiserum inhibited the hemagglutination reaction. This technique 
had been widely used in avian mycoplasma work, particularly in the 
measurement of antibody to M. gallisepticum (Fahey and Crawley, 1954). 
Crawley and Fahey (1957), and for the characterization of avian myco­
plasmas (Kleckner, 1960; Yoder and Hofstad, 1964; Dierks et_ al. 
1967). Apart from avian mycoplasmas, only a few strains of animal 
mycoplasma produce a direct hemagglutination and at very low titer 
(Manchee and Taylor-Robinson, 1968). Of the mycoplasmas of human 
origin, only M. pneun.c ; i le uaa agi, ' in>v - antibody at low level 
(Somerson et a_l^. 1967), yet with tht ^ horse serum in 
the hemagglutination system, high level aaggliitination could 
be obtained. Hemagglutination appeared co be the mechanism by 
which horse serum diluent caused high hemagglutination titer of M. 
pneumoniae since both horse serum and M. pneumoniae had hemagglutina­
tion to vervet erythrocytes (John et^ al. 1966). 
The hemadsorption of mammalian erythrocytes to colonies of 
M. pneumoniae was reported by Del Giudice and Pavia(196A). Myco-
plasam from avian and animal sources, i.e., M. gallisepticum, M. 
agalactiae, M. bovigenitalium. and M. pulmonis could hemadsorb 
erythrocytes from a wide range of species , Hemadsorption was 
reduced by growing of colonies on agar and by the addition 
of specific antiserum to the colonies. Generally the antisera 
titers obtained by hemadsorption inhibition were low in comparison 
with those obtained by metabolic inhibition and therefore it was not 
useful for routine serologic testing (Manchee and Taylor-Robinson, 1968). 
The adsorption of M. pneumoniae and M. gallisepticum to red 
blood cells appeared to depend upon neuraminic acid receptors on the 
red blood cells, whereas M. orale and M. plumonis seemed to utilize 
other types of receptors. Pretreatment of red cells with receptor 
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destroying enzyme, neuraminidase, or influenza B virus, removed the 
adsorption receptors for M. pneumoniae. Similarly, pretreatment of 
M. pneumoniae colonies with neuraminic acid containing material pre­
vented adsorption of erythrocytes. The mycoplasma receptor sites 
were thought to be lipid or lipoprotein in nature (Sobeslavsky et al. 
1968), or protein in nature (Manchee and Taylor-Robinson 1968). The 
adsorption of mycoplasma to neuraminic acid receptors of various cells 
has been postulated to have a role in virulence of M. pneumoniae since 
this type of attachment provides an unusual opportunity for peroxide, 
secreted by the organism, to attack the tissue cell membrane without 
being rapidly destroyed be catalase or peroxidase presented in extra­
cellular body fluid (Sobeslavsky et a^. 1968). 
Formalized M. gallisepticum can be used for hemagglutination and 
in the hemagglutination-inhibition tests. The antigen retained its 
hemagglutination ability for an extended period (Ad1er and DaMassa 
1967). 
Indirect hemagglutination test 
Tannic acid agglutination of red blood calls has been known for a 
long time. Reiner and Fischer (cited by Herz and Kaplan, 1968) described 
the possible mechanism of the effect. They suggested that tannic acid 
altered the surface properties of the erythrocytes, changing them from 
a hydrophilic to a hydrophobic state. Freund (1929) assumed that tannic 
acid, like homologous antibody, brings about a change in the surface po­
tential of the cells, which in the presence of certain electrolytes 
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results in their aggregation. 
Treatment of erythrocytes with tannic acid causes a reduction 
in anion permeability (Edelberg, 1952), and an alteration of osmotic 
resistance (Bohmann, 1944). Exposure of human erythrocytes to tannic 
acid under conditions commonly employed in indirect hemagglutination 
tests, resulted in irreversible inactivation of acetyl choline 
esterase, a membrane enzyme (Herz, 1968). It had been suggested 
that in low concentration tannic acid traversed the erythrocyte 
membrane (Bohmann, 1944), yet Herz and Kaplan (1968) have demonstrated 
that cytoplasmic enzymes were not affected when intact erythrocytes 
were exposed to tannic acid in conditions which caused irreversible 
inactivation of acetyl choline esterase (Herz, 1968). This finding 
does not support the contention that tannic acid is able to traverse 
the red blood 'cell membrane, but indicates that this agent only inter­
act with specific segments of the outer surface of the human erythro­
cyte membrane (Edelberg, 1952). 
Treatment of sheep red blood cells with suitable concentra­
tion of tannic acid rendered them capable of adsorbing certain 
protein molecules from solution. Red blood cells which have ad­
sorbed in this way are agglutinated by homologous antiserum (Boyden, 
1951). This method of detecting antigen-antibody reaction was further 
standardized by Stavisky (1954). 
Treatment of red blood cells with tannic acid facilitated the 
attachment of Mycoplasma mycoides. When the antigen-coated red 
blood cells came in contact with specific antibody, hemagglutination 
resulted (Anon., 1957). 
23 
Dowdle and Robinson (l9hA) successfully employed the indirect 
hemagglutination test Cor the diagnosis of mycoplasma infection and 
found that the test was immunologically specific and sensitive. The 
test was modified by Taylor-Robinson ejt a_l. (1964) and was used to 
identify mycoplasma and to establish their relationship with other 
mycoplasmas. Neimark (1968) and Lind (1968) further simplified the 
test by fixing antigen-coated tanned erythrocytes with glutarylal-
dehyde and formalin, respectively. The fixed erythrocytes were 
equally sensitive and could be stored for six months without losing 
activity. This finding greatly expanded the applicability of the in­
direct hemagglutination test to the diagnosis of mycoplasma infections. 
Serologic Tests Employed for the Diagnosis or Identification 
of Swine Mycoplasmal Diseases or Swine Mycoplasmas 
There are five established swine mycoplasma species. The 
serological test applied to each of the species is reviewed. 
Mycoplasmas hyorhinis 
An indirect hemagglutination test was developed for use with M. 
hyorhinis by Ross and Switzer (1963). Washed sheep red blood cells 
modified with antigens from heated M. hyorhinis cell suspensions were 
agglutinated by hyperimmune rooster, rabbit, or swine antisera^ How­
ever, sera from naturally or experimentally infected pigs did not 
consistently produce agglutination. These workers also found sero­
logical variations between the various isolates of M. hyorhinis. 
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Tully (1966) used immunofluorescence to compare two isolate» of M. 
hyorhlnis with several otlier species of mycoplasma and found those 
Isolates were similar to each other yet distinct from other mycoplasm 
examined. Purcell et^ aj^. (1966a) also found that M. hyorhinis was a 
distinct species but was very similar to several mycoplasma isolated 
from non-porcine sources. 
Mycoplasma granularum 
Dinter e^ a_l. (1965) showed that M. granularum is antigenically 
unrelated to other swine strains by both growth inhibition and gel-
diffusion studies. Immunofluorescence studies (Tully, 1966) had 
also revealed distinction between M. granularum and M. hyorhinis. 
Serological methods for the measurement of response of pigs to in­
fection have not been evaluated. 
Mycoplasma hyoarthrinosa 
Mycoplasma hyoarthrinosa has been demonstrated in the joint 
cavities of swine even in the absence of microscopic lesions in 
adjacent tissues by the use of indirect immunofluorescence (Robinson, 
e^ aj^. 1967a). Robinson £t al. (1967b) used an indirect hemagglutina­
tion plate test to monitor the serologic response in pigs experimen­
tally infected with M. hyoarthrinosa and found that the serological 
response varied from undetectable in several pigs to a titer of 1:614 
in one pig at nine days post-infection. The serologic response reached 
its maximum on the ninth day and declined afterward. 
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Mycoplasma hyogenitalium 
It was reported that this organism was serologically distinct 
from M. hyorhinis or M. granularum (Moore aj^. 1966) but the details 
of how this was accomplished were lacking. 
Mycoplasma hyopneumoniae 
Using the standard complement fixation (CF) test, Roberts (1968) 
detected antibodies to M. hyopneumoniae in pig sera. Boulanger and 
L'Ecuyer (1968) also demonstrated antibodies to the organism at two 
to three weeks after experimental infection by the use of a modified 
direct complement fixation test. The antibodies remained detectable 
for more than 200 days. An indirect CF test was also able to demon­
strate antibodies but the titer obtained was lower than with the 
modified direct test. These workers could differentiate M. hyo­
pneumoniae from M. hyorhinis by the CF test, however, when hyper­
immune rabbit sera were tested, only slight antigenic differences were 
observed and there was enough cross-reactivity to render this source 
of antibodies impractical for species differentiation. Takatori 
et al. (1968) also demonstrated CF antibodies in pigs experimentally 
infected with M. hyopneumoniae. They reported that antibodies first 
appeared two to three weeks after inoculation. The CF antigen of M. 
hyopneumoniae was stable to heat and trypsin and was associated with 
both ether soluble and insoluble fractions of the organisms. 
Goodwin e^ (1969) detected CF antibodies in pigs infected 
with M. hyopneumoniae and found no correlation between either the 
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extent of the pneumonic lesions or the immune state and the titer 
obtained. They also successfully employed an indirect hemagglutintion 
test for the detection of antibodies against M. hyopneumoniae. The 
mycoplasma antigens were prepared by concentrating organisms to one 
one-hundredth of the original volume. The appropriate antigen con­
centration used for the test was determined by block titration. 
This antigen dilution was then used to sensitize tanned sheep red 
blood cells. None of the sera from 12 pigs killed at 12 to 22 days 
postinfection had detectable titers. However, high indirect hemag­
glutination titers were obtained with sera from, pigs infected 16 or 
more weeks previously. 
Mycoplasma Vaccines and Vaccination Procedures Currently Used 
for Immunization Against Mycoplasma Infections 
Contagious bovine pleuropneumonia 
Vaccination against contagious bovine pleuropneumonia (CBPP) 
was based on the use of "culture vaccine" (Walker, 1921-22), which con­
sisted of a strain of the organism attenuated by serial culture for a 
varying number of generations in 10 per cent bovine serum broth. An 
initial course of three doses at intervals of three weeks was given, 
followed by a single yearly dose. Local reactions and levels of 
immunity following vaccination were variable. Vaccines of this nature 
was thought to increase the number of "carriers" and render control 
more difficult (Sheriff and Piercy,. 1952), Therefore, further work was 
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done to adapt a strain of CBPP organism to embryonated hens eggs. 
Cattle were immunized by the subcutaneous inoculation of ninth egg 
passage infected chorio-allantoic membranes. The cattle were chal­
lenged with virulent pleural exudates taken from CBPP infected cattle. 
Although there were occasional variations in virulence, the authors 
claimed that the avianized strain was a safer, more stable and more 
effective immunizing agent than those in use for the control of CBPP. 
The avianized vaccine, in a lyophilized state, was found to be 
viable after two and half years of storage vacuo in the frozen 
state. It was still capable of inducing immunity in cattle, and no 
appreciable properties had changed (Hyslop, 1955). 
Priestley (1955) prepared a vaccine by reconstituting the dried 
organism in a suitable fluid and immediately mixing with one per cent 
agar. After the agar had set, animals were inoculated in the tail with 
0.3 ml of the vaccine. Twelve but of 18 bulls tested gave positive 
flocculation reaction after 14 to 18 days. All animals were resistant 
to challenge with virulent CBPP agent. The authors also found evidence 
that cattle could be immunized with vaccines stored in the dry state 
for more than two months. Piercy and Knight (1955-56) propagated the 
organism in embryonated hens eggs, which were then used as the inoculum 
for vaccine production. They found vaccination with various lots of 
vaccines produced varying degrees of protection. They found that 
after 44 egg passages, the organisms failed to elicit an immune re­
sponse in cattle and concluded that early generations of adapted 
strains should be used for vaccine production. Later, Piercy and 
Knight (1958), in a trial with an attenuated vaccine strain demonstrated 
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that it conferred a significant degree of protection against challenge. 
Progressive passage through embryonated hens eggs did not lessen its 
immunizing ability for at least 18 passages. However, they still 
recommended the use of early generation egg adapted strains for 
vaccine production. 
The efforts of Piercy and Knight (1958) to increase the im­
munizing ability of vaccine by various manipulations were not very 
successful. They also observed the existence of naturally resistant 
animals which they considered to be a probable explanation of the 
failure of well attenuated vaccine to immunize the whole of any given 
cattle population. 
Poultry mycoplasma infections 
Van Rockel et al_. (1953) reported that resistance to challenge 
was increased in birds recovered from M. gallisepticum infection. 
Adler (1958) however, was not able to protect turkeys with various 
killed vaccines or with cultures of this organism propagated in broth. 
Adler e^ al. (1960) prepared live and killed vaccines and inoculated 
chickens by various routes. They then challenged the birds with 
virulent M. gallisepticum and found that a vaccine prepared by sonic 
disruption of the organisms did not produce immunity in chickens. 
Similarly, an aluminum hydroxide-adsorbed formalin-inactivated vaccine 
did not immunize chicken. Only an attenuated live culture vaccine 
administered intramuscularly immunized the chickens for about two 
months. Turkeys did not respond to the vaccine. 
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Warren et^ aj^. (1968) prepared a vaccine by formalin inactivation 
M. gallisepticum harvested from broth or from a glass surface. The 
formalinized vaccine increased resistance of one-day-old chicks to 
air sac infection by the homologous strain of the organism when it 
was administered by intranasal or subcutaneous routes. 
Human mycoplasma pneumonia 
Couch e^ aj^. (1964) propagated ^  pneumoniae, human primary 
atypical pneumonia agent, on an agar surface and in tissue culture 
in attempt to attenuate the agent. They harvested the organism and 
inoculated 42 antibody-free volunteers via the nasopharynx. Thirty-
eight of these volunteers developed serologic evidence of infection 
and the agent was recovered from 21 of 27 volunteers. Twenty-three 
of the 42 developed detectable illness after inoculation including 
eight who developed febrile illness. These workers also found 
that pneumonia and bullous myringitis occurred in those volunteers 
inoculated with tissue culture propagated agents but not in those 
receiving the agar-grown agents. This difference suggested that 
propagation on a cell-free agar medium resulted in a decrease in the 
virulence of M. pneumoniae for man. It also indicated that it might 
be possible to develop suitable attenuated strain of M. pneumoniae 
for use in immunoprophylaxis. 
Jensen et al. (1965) used a chemically defined medium for the 
production of a Mycoplasma pneumoniae vaccine. The vaccine, after 
formalin inactivation, was studied in animals and human subjects. It 
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was found to elicit antibodies in rabbits and monkeys and induced 
resistance to multiplication of mycoplasma in the lung of vaccinated 
hamsters. It was well tolerated in preliminary studies with 36 
human subjects. Encouraging evidence of antigenicity was obtained 
when 25 of 30 subjects developed significant rise in mycoplasma 
growth - inhibiting antibody titers. It was concluded that the vac­
cine would probably confer some protection against naturally occurring 
or experimentally produced infection, however, the extent of protec­
tion was not determined. 
Other formalized vaccines for M. pneumoniae were prepared by 
Metzgar et al. (1966), These vaccines were aqueous or were inco-
porated in alum or emulsified peanut oil adjuvant. All of the vac­
cine preparations were highly antigenic in animals and in man. Alum 
vaccines were better than aqueous vaccines, and those in adjuvant 
(peanut oil) appeared to give the best results. Furthermore, no local 
or systematic reactions of clinical consequence was noted in any 
person vaccinated. There was evidence that alum vaccine stimulated 
a high degree of protective antibody in pre-school children and that 
it protected children and adults against disease. 
Weibel e^ a_l. (1967) followed up this work and noted that the 
vaccine given |in two doses one month apart, stimulated homologous 
antibody. As the result of the vaccination, a 28 per cent reduction 
in mild cases, and a 35 per cent reduction in severe Illness was noted. 
The reduction in severe cases was difficult to evaluateibecause the 
number of cases was small. 
The studies of Smith et al. (1967) on Metzgar's vaccine showed 
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that it produced protective and growth inhibiting antibodies in 
about 50 per cent of the volunteers. One of the individuals that 
had an antibody level became ill after infection, however, illness 
occurred in 10 of 13 men in a control group. The protective action 
of the vaccine was statistically significant ({>< 0.004). It was also 
suggested that the vaccine-induced growth inhibiting antibody was 
associated with significant, but not complete, protection against 
experimental infections. 
In contrast to the protective effect, an anomalous effect was 
observed in volunteers who did not develop detectable antibody 
following vaccination. Experimental infection of this group led to 
more severe illness than that observed in the control group. There­
fore, they warned that caution should be exercised when an inactivated 
vaccine of low potency was evaluated in man. These workers also 
found that after prolonged passages in artificial medium, M. 
pneumoniae became less infectious, however, the property of virulence 
for man could not be completely disassociated from that of infection. 
Studies of Mogabgab (1968 a,b) on the protective effects of 
the inactivated Mycoplasma pneumoniae vaccine prepared by Metzgar 
et al. (1966) also supported the findings that the vaccines were 
effective. In military recruits receiving vaccines, three-fourths 
of the men developed a neutralizing antibody following a single in­
jection of vaccine. The second dose did not increase the response 
appreciably. The degree of immunity provided by the vaccine was, as 
evaluated by this worker, adequate. 
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Swine mycoplasma vaccines 
Betts £l. (1955) stated that there was no field evidence 
to show that a natural attack of enzootic pneumonia produced any appreci­
able degree of immunity, however, Lannek and Bornfors (1957) showed 
that a strong immunity developed in experimentally induced pneumonia. 
Pigs were infected, allowed to recover and then challenged 118 days 
after the primary infection. All the challenged pigs were free 
from enzootic pneumonia at slaughter, whereas all the positive con­
trols had pneumonia. Goodwin et. (1969) also found that pigs 
recovered from the disease were strongly immune to challenge and no 
lung lesions developed when inoculated with lung suspensions that 
produced extensive lesions of enzootic pneumonia in control animals. 
A tissue culture derived M. hyorhinis, a frequent contaminant 
in swine pneumonia, is prepared as a vaccine for the prevention of 
swine enzootic pneumonia (Pfizer, Inc. 1968). The vaccine is in­
activated by adding formalin. Alumnium hydroxide gel is used as an 
adjuvant. The manufacturer recommends all gilts, sows and boars be 
vaccinated. Vaccination is repeated six weeks later. Pregnant 
gilts and sows should be vaccinated ten to 30 days before each far­
rowing; boars are vaccinated twice a year. 
The vaccination is given subcutaneously and the dosage is 20 ml 
for each vaccination. No side effects were reported. The vaccine is 
claimed to be able to free pigs in heavily infected herds from 
symptoms of pneumonia a few months after vaccination. 
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MATERIALS AND METHODS 
Source of Mycoplasma hyopneumoniae 
Mycoplasma hyopneumoniae strain #11 (L'Ecuyer, 1962) was 
used throughout the course of the study. This strain was isolated from 
a pig that had gross consolidation of the apical and cardiac lobes of 
the lung. It was maintained in cell-free medium and was able to 
reproduce typical pneumonic lesions in experimental pigs 80 to 
100 per cent of the time (Mare, 1965). A detailed history of this 
strain has been documented (Huhn, 1968). A lyophilized culture 
derived from the 20th passage of this organism in cell-free medium 
was used as the initial inoculum. The culture was subcultured at 
three to four day intervals and incubated at 37°C. 
Culture Media and Growth of Mycoplasma 
Liquid medium 
Dulbecco's phosphate buffer (DPB) was used as the basis of a 
liquid medium for the growth and isolation of Mycoplasma hyopneumoniae. 
The formulation and preparation of components of DPB medium was as 
follows : 
A. Dulbecco's phosphate buffered saline 
Dulbecco's buffered phosphate saline was prepared as 
described (Dulbecco and Vogt, 1954). 
B. Swine serum 
Swine serum was processed according to the method of Sachs 
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(cited by Boulanger, 1954). 
1. The pH of the serum was adjusted to between 4.3 to 4.5 
with 1 N HCl, being careful not to allow it to drop 
below pH 4.2. 
2. Allow to stand overnight at 4 C. 
3. Centrifuge serum at 590 xG for 15 minutes; discard 
sediment. 
4. Supernatant was then clarified through Whatman GF/A 
glass filter pad and Selas #10, #01, and #02 filters. 
5. The pH was adjusted to 7.0 with 1 N NaOH. 
6. Store at -20 C until use. 
C. Lactalbumin hydrolysate* (Enzymatic) 
Lactalbumin hydrolysate was added to the medium at 
a final concentration of 0.5 per cent. 
D. Yeast extract (Hayflick, 1965) 
Yeast extract was prepared by the following procedure: 
1. Add 250 gm of yeast** to 1 liter of distilled water. 
2. Heat to boiling and stir. 
3. Filter through two sheets of Whatman #1 filter paper. 
4. Adjust the pH to 8.0 with 1 N NaOH. 
5. Dispense in 5-8 ml aliquote, and autoclave at 15 
pound pressure for 15 minutes. A precipitate may 
form after autoclaving, avoid using the precipitate. 
Nutritional Biochemicals Corporation, Cleveland, Ohio. 
** 
Fleischmann type 20-40 yeast. Standard Brands Inc. 
New York, New York. 
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6. Store at -20 C until use. 
7. The yeast extract was used at a final concentration 
of 1 per cent. 
E. Dextrose 
Sufficient dextrose was added to give a final concen­
tration of 0.25 per cent. 
F. The DPB medium was prepared by combining the following 
materials : 
Dulbecco's phosphate buffer 790 ml 
Lactalbumin hydrolysate 5 gm 
Yeast extract 10 ml 
Dextrose 2.5 gm 
Swine serum 200 ml 
1. The pH was adjusted to 7.4 with 1 N NaOH. 
2. The medium was clarified through Selas #10, and 
#01 filters. 
3. The medium was sterilized through a Selas #02 or #03 
filter. 
4. It was then tubed in screw-caped tubes or flasks. 
5. The medium was incubated at 37 C for 48 hours and 
then stored at 4 C until used. 
Solid medium 
The solid medium was composed of the following materials: 
* 
A. Agar 1 gm 
Hank's balanced salt solution** (IX) 20 ml 
*Bacto agar, PPLO agar or Noble agar: Difco Laboratories Inc. 
Detroit, Mich. Oxoid agar: Calab Laboratories, Inc, Chicago Heights 
* Microbiological Associates, Bethesda, Maryland. 
36 
The pH was adjusted to 7.4 and the mixture autoclaved 
at 15 pound pressure for 15 minutes. 
B. Filter sterilized DPB medium 80 ml 
After cooling the agar preparation to 50 C and warming 
the DPB medium to 50 C, A and B were mixed and pipetted 
in six to seven ml amounts into plastic petri dishes*. 
The agar congealed at room temperature. The plates were 
then incubated at 37 C overnight. 
Growth of organism in fluid medium for routine maintanance 
Each culture tube containing about six ml of DPB medium, 
was inoculated with 0.6 ml of approximately four-day-old mycoplasma 
culture. The culture was incubated at 37 C. 
Growth of organism in fluid medium for antigen production 
Fifty ml of three-day-old culture was inoculated into 500 ml 
of DPB medium in a screw-caped flask and incubated at 37 C. After 
five days incubation, the organisms were harvested by centrifuga-
tion at 18,000 rpm (35,000G) for 30 minutes in a Beckman model 
L-2-65 preparative ultracentrifuge. The sediment was washed twice 
with phosphate buffered saline (PBS) (pH 7.4) and finally re-
suspended in deionized water. The amount oS water added to resuspend 
the sediment was 1/100 of the original volume of the culture medium. 
*Falcon Plastics, Division of B-D Laboratories, Inc., Los 
Angeles, California. 
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Growth of orKanism on solid medium 
One-tenth ml of a three-day-old mycoplasma culture was 
inoculated onto the surface of the agar. It was incubated at 37 C 
for two to three hours to obtain initial drying. It was then 
sealed in a plastic bag to prevent excess evaporation and incubated 
at 37 C in an inverted position. Daily examination of the surface 
of the plates with a dissecting microscope was made for 10 days. 
Growth of organism on plastic and glass surface 
Ten ml of DPB medium was added to a plastic* or glass flask** 
and one ml of three-day-old M. hyopneumoniae culture was inoculated 
into it. The flasks were incubated at 37 C. The culture fluid 
was decanted and fresh medium added every fourth day. Frequent 
microscopic examination was made to see whether the organism was 
able to attach and grow on the glass or plastic surface. 
Swine Infection Procedures 
Source of experimental swine 
All pigs used in this work were obtained from the respiratory 
disease free heard maintained at the Veterinary Medical Research 
Institute, Iowa State University. This herd is founded on surgically 
derived stock and has been free of respiratory disease for more than 
*Falcon Plastics, Division of B-D Laboratories, Inc., Los 
Angles, California. 
Corning Glass Works, Coming, New York. 
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16 years. Most of the pigs used were Yorkshires and Hampshires 
although a few cross-breds between the two were used. The age of 
the pigs used in the experiments ranged from 6-14 weeks. 
The experimental pigs were housed in strict isolation for 
the duration of each experiment unless otherwise specified. In 
all cases the pigs were alloted to treatments by randomized selection 
of numbers. The pigs were fed a complete 17 per cent protein ration 
free of antibiotics. 
Infection of pigs 
Each pig was given five ml of a three-day-old culture of M. 
hvopneumoniae daily for three days. The culture was administered 
by intranasal instillation with the snout of the pig held in an 
up-right position as the culture fluid was dripped slowly into 
the nostril. Pigs were necropsized after observation periods 
ranging from three weeks to 11 months depending on the nature of the 
experiment. 
Necropsy examination 
All pigs were electrocuted and exsanguinated. Blood and lung 
tissue were collected for various purposes as indicated. 
Tissue sections 
Lung tissues were collected and fixed in 10 per cent formalin 
immediately after death. After three days fixation, the tissues 
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were trimmed, processed and embedded in paraplast* tissue embed­
ding medium. They were sectioned at six micron and mounted on 
glass slides with an albumin fixative. All sections are stained 
with Harris's hematoxylin and counter stained with eosin Y (U.S. Armed 
Force Institute of Pathology, 1960). 
Blood 
Collected blood was allowed to clot at room temperature, and 
the serum separated by centrifugation. It was then stored at -20 C 
until use. None of the serum samples used in this study were heat 
inactivated. 
Mycoplasma isolation 
Portions of lung lesions were aseptically removed and ground 
in the presence of DPB medium. Five-tenth ml of the lung homo-
genate was inoculated into a tube of DPB medium for the isolation 
of M. hyopneumoniae. Two hundred I.U/ml of penicillin was added 
to the medium to retard the growth of contaminants. The inoculated 
medium was incubated at 37 C and subcultured at two-day-intervals. 
The isolation attempt was considered to be negative if growth of M. 
hyopneumoniae could not be demonstrated after 10 transfers. 
ic 
Sherwood Medical Industries, Inc., St. Louis, Mo. 
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Demonstration of the presence of M. hyopneumoniae 
Cultures grown in DPB medium were used for the demonstration 
of growth of hyopneumoniae. Portions of the medium were taken 
out and centrifuged at approximately 590 xG for 15 minutes. A 
smear of the sediment was prepared on a glass slide. The slide 
was then fixed cind stained according to the procedures described 
by Mare (1965), and examined for the presence of Mycoplasma hyo­
pneumoniae . 
the following: 
A. KH2PO4 0.9078 gm in 1,000 ml of 0.85% NaCl 
B. NagiHPO^ 1.4845 gm in 1,000 ml of 0.857» NaCl 
The desired pH was achieved by varying the proportions of the 
two solutions. The pH 7.4 PBS was made of 19 ml of A and 81 ml 
of B, and the pH 6.4 contains 73 ml of A and 27 ml of B. 
Veronal buffered saline (VBS) A VBS described by Hirsch-^ 
feld (1960) was used for immunoelectrophoresis. It was composed 
of the following: 
Serological Tests 
Preparation of buffered solutions 
Phosphate buffered saline (PBS) The PBS was composed of 











10 liter 10 liter 
The pH of both of the buffers was 8.6. 
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Preparation of antigens 
Mycoplasma hyopneunioniae cultures were concentrated one-
hundred fold by centrifugation and then suspended in distilled 
water. The sedimented organisms were processed in three ways to 
make three different antigens. 
Ant igen 1 The lOOx concentrated organisms were alternatively 
frozen in a solid carbon dioxide-alcohol bath and thawed in 70 C 
running tap water. After 20 cycles of freezing and thawing, an 
appropriate amount of NaCl and merthiolate" were added to make a 
final concentration of 0.85 per cent and 1:10,000 respectively. 
It was then stored at 4 C. This antigen preparation was designated 
as Antigen I. 
Ant igen II Adequate two per cent sodium lauryl sulfate** 
(SLS) in distilled water was added to lOOx the concentrated myco­
plasma suspension to make a final concentration of SLS of 0.2 per 
cent. The cloudy suspension cleared within minutes. The suspension 
was then dialyzed against 5 M ammonium sulfate (pH 8.0) overnight. 
The precipitate was pelleted and then dialyzed against pit 7.4 PBS for 
48-72 hours to remove ammonium sulfate. Merthiolate was added to 
a final concentration of 1:10,000, and it was then stored at 4 C. 
This antigen preparation was designated as Antigen II. 
Antigen III One part of solution containing two per ciuit 
SLS and two per cent sodium desoxycholate (DOC) was added to nine 
parts of tlie lOOx concentrated mycoplasma suspension to lyse 
*Eli Lily and Co., Indianapolis, Indiana. 
**Sigma Chemical Corporation , St. Louis, Missouri. 
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the organisms. Then a volume of 24 per cent ammonium sulfate 
equal to that of the lysed organisms was added and the mixture 
allowed to stand at room temperature for 30 minutes. The floc­
culating material was pelleted by centrifugation at 2,000 rpm 
(590 xG) for 15 minutes and resuspended in pH 7.4 PBS. The process 
of SLS-DOC lysis and ammonium sulfate precipitation was repeated 
once. The second sediment was reconstituted to the starting volume 
with PBS] and dialyzed against PBS for 48-72 hours to remove am­
monium sulfate. Merthiolate was added to make a final concentration 
of 1:10,000. The antigen preparation was then stored at 4 C and 
was designated as Antigen III. 
Production of antisera 
Experimentally infected pig sera Experimental pigs were 
inoculated intranasally with Mycoplasma hyopneumoniae and were 
bled at frequent intervals after inoculations. The sera of the 
pigs were collected, separated and stored at -20 C. 
Hyperimmune pig sera Pigs were inoculated with vaccines 
G and F intramuscularly. Details of vaccine preparation and 
vaccination procedures are presented in the section on Active 
Immunization Trials. 
Vaccinated pigs were bled at weekly intervals, and were 
infected with three doses of three-day-old mycoplasmas culture two 
weeks after the last vaccination. The pigs were necropsied three 
weeks later. Blood was collected from the pigs, the sera separated 
and stored at - 20 C. 
43 
Naturally infected pig sera Blood samples from either 
conventional or specific pathogen free (SPF) herds were obtained 
through various cooperating veterinarians. Some of the samples 
were from herds that had a history of pneumonia whereas others were 
from herds that had no known history of pneumonia. Sera from the 
blood samples were separated and stored at - 20 C. 
Treatment of sera with mercaptoethanol One per cent 
2-mercaptoethanol^ was prepared in PBS pH 7.4. One tenth ml of 
2-mercaptoethanol was added to 0.9 ml of serum and incubated at 
37 C for one hour. The treated serum was then dialyzed against 
PBS pH 7.4 for 24 hours to remove 2-mercaptoethanol, and the dia-
lyzate was tested and compared with untreated serum by means of the 
indirect hemagglutionation test. 
Indirect hemagglutionation test 
Swine red blood cells (rbc), collected from the anterior vena 
cava, were washed three times at 1500 rpm (340 xG) with PBS at 7.4. 
One ml of the washed and packed cells was then resuspended in 80 ml 
ick 
of 1:40,000 tannic acid in pH 7.4 PBS and incubated in a 37 C water 
bath for 15 minutes. The tannic acid treated cells were then sedi-
mented by centrifugation at 2000 rpm (590 xG) and the pellet washed 
once and finally resuspended in adequate amount of PBS pH 7.4 to give 
a 10 per cent rbc suspension. 
*Sigma Chemical Co., St. Louis , Missouri 
**Mallinkrodt Chemical Works, St. Louis, Missouri 
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For the indirect hemagglutination test, 0.5 ml of 10 per 
cent rbc, 0.3 ml of antigen I, II or III, and 2 ml of pH 6.4 
PBS were mixed and incubated in a 37 C water bath for 20 minutes. 
The antigen treated cells were then centrifuged at 1,500 rpm (340 xG) 
for five minutes and washed once with PBS pH 7.4. The pellet was 
resuspended in adequate PBS pH 7.4 to make a final concentration of 
one percent. 
The antiserum dilution was carried out in plastic trays* with 
U-shaped wells. PBS with two per cent gelatin was used as the 
diluent. To each well was added 0.05 ml of diluent. Five one-
hundredth ml of serum was added to the first well in a series. Dilu-
tions were made by means of a diluter which carried 0.05 ml of 
fluid from one well to the next thus making a two-fold dilution. 
Twenty-five thousandth ml of one per cent antigen treated red 
blood cells was added to each well containing serially diluted 
antisera by means of a dropperf The plate was then sealed with a 
plastic sealer, shaken for one minute on a shaking table^^, and 
incubated at 37 C for one hour. The results were read, following 
incubation, with the aid of a mirror and recorded. 
Preservation of antigen coated red blood cells 
A. The procedure of Dowdle and Heyward (1968) was used for the 
preservation of antigen coated rbc. Briefly, adequate antigen 
*Limbro Chemical Co. Inc., New Haven, Conn. 
**Cooke Engineering Co., Alexandria, Virginia. 
'^Cooke Engineering Co., Alexandria, Virginia. 
'^^Arthur H. Thomas Co., Philadelphia, Pa. 
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treated rbc were added to I ; IOO horse serum dilutint in 0.85 per 
c'-nt sal in'- which contained II per cent po I yv: ny I pyro I idone, to 
make a final rbc concentration ol" five per cent. Two ral of: the 
rbc were then distributed to ampules, quickly frozen in a dry ice-
alcohol bath, sealed, and stored at -70 C. Untreated rbc were 
similarly preserved and served as a control. 
B. The procedures of Hubert et aj^. (1963) were used. Antigen-
coated rbc were diluted to 0.05 per cent final concentration with 
PBS pH 7.4 as the diluent, and an equal amount of a mixture of 
freshly prepared 10 per cent dextrose and 15 per cent lactose in 
distilled water was added. Two ml of the rbc-preservative mixture 
were transferred to an ampule which was then sealed, quickly frozen 
and stored at -70 C. 
Selected ampules were thawed each week. The rbc were pelleted 
by centrifugation, and resuspended to the original volume with PBS 
pH 7.4. A total intact rbc count was made to determine the extent 
of cell lysis under the conditions of preservation. 
Agar gel diffusion test 
The double diffusion technique of Ouchterlony (1949) was used. 
The diffusion agars were prepared as follows: 









Difco Laboratories, Inc., Detroit, Michigan 
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C. Veronal buffered saline 100 ml 
Noble agar 1 gm 
All preparations were autoclaved at 15 pound pressure for 
15 minutes. Seven ml of hot agar wore pipetted to plastic petri 
dish and allowed to congeal at room temperature. The wells were 
cut with the aid of a gel punch assembly^; the distance between 
each well was seven mm. 
Two tenth ml of pre inoculât ion and 2, 4, 6, 8 and 10 weeks 
post inoculation sera from experimentally infected pigs were 
pipetted into surrounding wells and ran against 0.2 ml of Antigen I, 
II and III, respectively, in the center reservoir. The plates 
were incubated at 37 C overnight prior to examination. 
Immunoelectrophoresis 
The procedures of Hirschfeld (1960) were used. The veronal 
buffered solutions described previously were used for the immuno-
cell and gel. Gel buffer was diluted five times and one per cent 
Noble agar added. The agar was then autoclaved at 15 pound pressure 
for 15 minutes and two ml of hot agar was spread on the surface 
of a clean glass slide and allowed to solidify. The appropriate 
holes and trough were made with the aid of a cutterf 
The test samples were added to the wells and the electro­
phoresis was accomplished in an immuno-cell for 90-100 minutes. 
'"^GRAFAR Corp., Detroit, Michigan-
**E-C Apparatus Corp., Philadelphia, Pa. 
^Buchler Instruments, Fort Lee, New Jersey. 
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The agar in the center trough was then peeled off and rabbit 
anti-porcine sera added to the trough, and the slide incubated 
overnight at 37 C in an moist chamber. The slide was dried fol­
lowing incubation, and washed with saline for five to six hours 
to remove excess protein and dried again. The dried slide was then 
stained with amido black (2%) followed by destainlng in a destaincr 
containing alcoliol, water and acetic acid in the ratio 5:5:1. 
The stained slide could be kept for a long period of time. 
Metabolic inhibition test 
The metabolic inhibition test of Taylor-Robinson et al.(1966a) 
was used with slight modification. The test was carried out in 
acid cleaned, sterile, screw-capped glass tubes. Each tube contained 
0.4 ml DPB medium containing one per cent horse serum. Four-tenth 
ml of four week post-infection sera was added to the first tube and 
a two-fold dilution of serum made. To each dilution was added 0.4 ml 
of three-day-old culture and incubated at 37 C. The tubes were 
examined daily for 10 days. 
Stability of antigen 
Antigen preparations were stored at 4 C. Aliquots of anti­
gens were taken out at weekly intervals to sensitize swine rbc for 
the indirect hemagglutination test. A pre-inoculation, a hyper­
immune and a 120 day post-Infection sera were used to determine the 
stability of antigens in storage, 
*Hyland Division, Travenol Laboratories, Inc., Los Angeles, Calif. 
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Specificity of the indirect hemagglutination test 
Preliminary observations indicated that Antigen II worked 
best in the IHA test so this antigen was used for the determination 
of the specificity of this test. Sera from pigs infected with M. 
hyopneumoniae, M. granularum, M. hyorhinis, and from horses hyper-
Immunizcid with Erysipelothrix insidiosa* were tested for their 
respective reactivity with Antigen II sensitized rbc. Comparison with 
the CF test (Takatori et. fl.- 1968) was also made. 
Duration of passively transferred antibody 
Thirty ml of pooled antiserum derived from pigs vaccinated 
with vaccine F was filter sterilized and injected intraperitoneally 
into each of three pigs weighing 20 to 30 pounds. The pigs were 
bled at frequent intervals and the sera of those pigs were tested 
by means of indirect hemagglutination test for antibodies to Myco­
plasma hyopneumoniae. Antigen II was used for the IHA test. 
Antiserum derived from pigs vaccinated with vaccine G was 
similarly treated. The blood samples drawn from the three pigs 
used for this experiment were also tested for detectable antibodies 
to M. hyopneumoniae. 
Active Immunization Trials 
All actively immunized pigs were inoculated intramuscularly 
with one ml of the appropriate vaccine preparation. A week later 
_ 
Professional Biological Co., Denver, Colorado. 
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they were inoculated with two ml, and another week later with three 
ml of the same preparation administered by the same route. All 
the immunized pigs were challenged with five ml of three-day-old 
M. hyopneumoniae culture each day for three days, two weeks after 
the last inoculation unless otherwise stated. 
Experiment I 
The one hundred-fold concentrated suspension of organisms 
was extracted with three volumes of ether. The mixture was gently 
shaken a few times and then left at 4 C overnight. The ether 
soluble fraction was aspirated off and the remaining aqueous phase 
was dialyzed against distilled water for 18 hours. The dialyzate 
was then mixed throughly with an equal volume of incomplete Freund 
adjuvant. Five hundred units per ml of penicillin and 500 ug/ml 
of streptomycin were added to the vaccine to prevent the growth of 
contaminants. This vaccine was designated as vaccine A. 
Four pigs were injected intramuscularly with the vaccine. They 
were challenged with three doses of live mycoplasma culture two weeks 
after the last vaccination. A group of four pigs served as positive 
controls and were also challenged with three doses of mycoplasma 
culture. All pigs were necropsied three to four weeks postexposure. 
Experiment II 
This vaccine was prepared the same as vaccine A except that 
0.3 per cent formaldehyde replaced the antibiotics. The preparation 
was designated vaccine B, 
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Four pigs were vaccinated and another four served as positive 
controls. They were necropsied four weeks post-infection. 
Experiment III 
Four pigs were infected by intranasal exposure to three doses 
of M. hyopneumoniae culture. Three weeks later they were immunized 
with vaccine B. The immunization scheme was the same as described 
in Experiment I. The pigs were necropsied two weeks after the last 
inoculation to determine the effect of immunization on elimination 
of lesions in infected pigs. 
Experiment IV 
The vaccine used in this experiment was the same as that de­
scribed in Experiment II. However, the pigs in this trial received 
only two doses of vaccine at weekly intervals, and the dosage for 
both vaccinations was two ml each. 
Four pigs were vaccinated and another four served as positive 
controls. They were infected on three consecutive days with three-
day-old M. hyopneumoniae culture and necropsied three weeks post­
exposure . 
Experiment V 
The 100-fold concentrated organsims were lysed with two per cent 
SLS, extracted with ether overnight and then dialyzed against dis­
tilled water for 48 hours. An equal amount of incomplete Freund adjuvant 
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was added to the dialyzate and sufficient formaldehyde was added 
to make a final concentration of 0.3 per cent. This vaccine was 
designated as vaccine C. 
Eight pigs were used. Four were vaccinated and the other four 
served as positive controls. They were necropsied four we%ks after 
infections. 
Experiment VI 
Vaccine C was used in this trial. Four pigs received two 
doses of two ml each a week apart. They were exposed to M. hyo-
pneumoniae culture two weeks after the last vaccination. Four un-
vaccinated control pigs were also exposed at the same time. All 
pigs were necropsied four weeks postinfection. 
Experiment VII 
Vaccine C, as well as a modification of it was used in this 
experiment. This modification consisted of omission of the ether 
extraction step. The modified preparation was designated as vaccine 
D. 
Fifteen pigs were used in this experiment; three of the pigs 
received vaccine C, six received vaccine D and the remaining six 
received no vaccine. A week after the first vaccination, three of 
the six un-vaccinated pigs were infected with live culture. Two 
weeks after the last vaccination (four weeks after the infection) 
three of the six pigs receiving vaccine D were removed and housed 
with the infected pigs in an attempt to determine whether contact 
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infection would occur in vaccinated pigs. They were housed together 
for three months. 
The remaining six vaccinated pij^s and three un-vaccinated pigs 
were given an intranasal dose of live culturc' ol M. iiyopneumoniae 
daily for three days. They were necropsied 25 days after the last 
exposure. 
Experiment VIII 
Vaccine preparations E and F were used in this trial. The 
former was prepared from organisms lysed with a final concentration 
of 10 M SLS at 37 C for two hours. This lysate was mixed with an 
equal amount of incomplete Freund adjuvant. Vaccine F was prepared 
by freezing the organism suspension in a dry ice-alcohol bath fol­
lowed by thawing in 65-70 C running tap water; after twenty cycles 
of freezing and thawing, an equal amount of incomplete Freund adjuvant 
was added. Both vaccines had 500 i.u./ml of penicillin and 500 ug/ml 
of streptomycin added. 
Each vaccine was given to four pigs. One of the pigs receiving 
vaccine E died from a ruptured umbilical hernia and a second pig 
died of unknown causes during the course of the trial. All surviving 
pigs were infected with three doses of live Mycoplasma hyopneumoniae 
culture two weeks after vaccination along with a group of four 




Vaccine F and G were used. The preparation of vaccine G was 
as follows: 
The concentrated organisms were lysed with two percent SLS at 
room temperature for 15 minutes followed by dialysis against 1.3 M 
ammonium sulfate overnight. The precipitate was further dialyzed 
against distilled water to remove ammonium sulfate. An equal 
amount of incomplete Freund adjuvant and 500 i.u./ml of strepto­
mycin was added following dialysis. 
Eight pigs were given vaccine F and three were given vaccine 
G. They were infected with live M. hyopneumoniae culture along 
with four positive control pigs. All pigs were killed four weeks 
postinfection. 
Experiment X 
A three-day-old culture of M. hyopneumoniae was treated with 
formaldehyde at a final concentration of 1:2,000. The prepara­
tion remained at room temperature for 24 hours before it was used. 
The bacterin was designated as vaccine H. 
Four pigs were used for this trial. They received, by intra­
nasal instillation, five ml of the bacterin daily for three days. 
One week after the bacterin administration, they were infected with 
three daily doses of M. hyopneumoniae culture. Three pigs of about 
the same age served as positive controls and were infected and 
necropsied at the same time as those receiving bacterin. 
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Experiment XI 
This experiment was an enlarged version of Experiment VII and 
IX. Because of the larger number of pigs involved, they were 
housed in open pens instead of the usual isolation units. Fifty 
pigs were divided randomly into five pens with 10 pigs in each pen. 
One pig died from the porcine stress syndrome during transportion 
from the swine herd to the experimental area. Ten pigs in pen 1 
and five of the pigs in pen 3 were vaccinated with vaccine F. The 
pigs in pen 2 and the remaining five pigs in pen 3 received vaccine 
G; pigs in pens 4 and 5 served as negative and as positive controls. 
Serum samples were taken from each of the pigs before vaccina­
tion and two weeks after vaccinations. Five pigs in pen 5 were 
necropsied prior to infecting pigs with mycoplasma culture. The 
lungs were all grossly normal. All the remaining pigs were then 
infected with five ml of three-day-old M. hyopneumoniae culture daily 
for three days. The pigs in this trial were sacrificed four weeks 
after infection. 
Passive Immunization Trials 
Immune sera from appropriate source were sterilized by passing 
through Selas #10, #01.and #02 filters. All pigs in these trials 
received intraperitoneal injection of immune sera and were infected 




Sera from pigs receiving vaccine A were pooled and filter 
sterilized. Two pigs weighing about 40 pounds received 50 ml of 
the serum each and were infected with M. hyopneumoniae culture. 
Two pigs of about the same weight served as positive controls. 
The trial was repeated once with six pigs involved; three were 
immunized and the other three served as positive controls. All 
pigs were necropsied 21 days postinfection. 
Experiment II 
Sera from pigs receiving vaccine F were used. Thirty ml of 
serum was injected into each 20 to 30 pound pig. Three pigs were 
passively immunized with the serum and three others served as positive 
controls. All pigs were exposed to live organisms and were kept 
in isolation for 24 days before they were necropsied. 
Experiment III 
The experimental design in this trial was the same as that in 
Experiment II except that the antisera was derived from pigs receiving 
vaccine G. Six pigs were used in this trial. Four of them were 
passively immunized. Of these four, two were challenged with myco­
plasma culture along with two positive controls. The two remaining 
immunized but not challenged pigs were then housed with the infected 
positive control pigs in order to determine whether contact infection 
could be established in passively immunized pigs. All pigs were 
sacrificed three weeks postinfection. 
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Experiment IV 
This trial started concurrently with Experiment XI of the 
Active Immunization trial so that both trials shared the same 
positive controls. 
Ten pigs of 20-30 pound weight were used. They were inocu­
lated with 30 ml of pooled sera from pigs receiving vaccine G and 
were infected with mycoplasma culture four, 24 and 48 hours post-
immunization. They were sacrified four weeks postexposure. 
Statistical analysis of immunization results 
Chi-square was used for analysis of results obtained in both 
active and passive immunization trials. 
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RESULTS 
Growth of M, hyopneumoniae 
Liquid medium 
The growth of M. hyopneumoniae. in DPB could be visualized 
after two to three days of incubaLiun at 37 C by the development 
of a yellow color due to acid production. A delicate spiral of 
growth could be demonstrated by gently shaking the tube. 
Solid medium 
None of the agar preparations made in this study was capable 
of supporting the growth of M. hyopneumoniae as no typical "fried 
egg" colonies were seen. However, pin-head sized colonies with a smooth 
surface were seen regularly under 30X magnifications. When a block 
of agar containing these colonies was transferred to DPB medium, 
characteristic growth of mycoplasma was observed in the broth medium. 
Giemsa stained preparation of this growth revealed organisms 
characteristic of ^  hyopneumoniae. 
Growth on plastic surface 
Few Mycoplasma hyopneumoniae were able to attach to the plastic 
surface, and the attachment did not seem to be firm as it could be 
shaken off even with gentle motion. Mycoplasma hyopneumoniae is 
therefore considered unable to grow on plastic surface. 
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Growth on glass surface 
Patches of mycoplasma colonies were present on glass surface 
after five to seven days incubation and several changes 
of growth medium . The colonies were irregular in shape and size. 
The clumps of cells did not spread out and no confluent sheet of 
cells was observed. 
Demonstration of organism by Giemsa stain 
Small bluish-purple coccoid organisms, with an approximate 
size of 200-400 myU, were present in Giemsa stained preparations. 
The organisms were generally present in small clusters, but ring 
forms were occasionally seen especially in older culture. No 
filamentous or granular form were seen. 
Serologic Tests 
Indirect hemagglutination test antigens 
Sera with a titer of 1:12 or higher were considered positive 
in the indirect hemagglutination test. 
Antigen ^  This antigen detected antibodies in experimentally 
infected pigs 42 days after infection. Because this antigen was 
less sensitive than antigen II it was not used to any extent in this 
study. 
Antigen II The antibody response in experimentally 
infected pigs was detected 14 days post-infection with this antigen. 
It reached a peak on the 63rd to 77th day and remained there until 
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the 193rd day. The titers of antibody started to fall after that, 
but remained detectable 325 days after infection (Figure 1). 
The antibody response in pigs put in contact with those pigs 
that had been infected two months previously was detected seven to 
eight weeks post-exposure. It reached the maximum level at the 13th 
to 19th week post-exposure and remained at that level for more than 
28 weeks (Figure 2). 
Pigs that were put in contact with those that had just been 
infected with M. hyopneumoniae culture developed detectable anti­
bodies five to six weeks post-exposure. 
The antibodies were detectable in the vaccinated pigs seven 
days after the first inoculation and reached a peak on the 14th day 
(seven days after the second inoculation). The antibody titer did 
not increase further upon administration of the third dose of vaccine. 
Antigen III With this antigen, antibodies were detected on 
the 36th day after inoculation. They reached a peak on the 63rd 
day, remained there for 106 days, and declined gradually but re­
mained detectable 320 days post-infection. This antigen prepara­
tion was more sensitive than Antigen I but was less sensitive than 
Antigen II and therefore was not used extensively for serological 
tests. 
Indirect hemagglutination test for the detect ion of experimentally 
infected pigs 
Antigen II was used for this study. Three groups of pig sera 
were tested. All of the pigs in these three groups were experimentally 
Figure 1. Serologic response to experimental infection 
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Figure 2. Serologic response to contact infection 
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infected and necropsied three to four weeks post-inoculation. 
Group I contained 24 pigs of which 20 developed lung lesions 
following experimental inoculation. Nineteen out of the 20 pigs 
with lesions were serologically positive. One of the pigs with 
lesion did not have an antibody titer. Among the four lesion-
less pigs, one was serologically positive while the other three 
were negative. 
There were 20 pigs in Group II. Among them, four were un­
infected controls which were all negative for M. hyopneumoniae anti­
bodies when tested by IHA test. All of the inoculated pigs developed 
lesions, and 15 out of 16 were serologically positive. 
Group III was composed of 30 pigs. Among them, 26 pigs 
developed pneumonic lesions. Twenty-three of those 26 pigs with 
lesion were serologically positive while the remaining three were 
negative. Two of the four lesionless pigs were serologically 
positive, while the other two were negative (Table 1). 
Indirect hemagglutination test for the detection of 
naturally infected pigs 
Twenty-two herds of pigs of various origins and locations 
had been examined for the presence of Mycoplasma hyopneumoniae 
antibodies. Among them, only one herd was consistently free of 
antibody. The others had detectable antibodies in one of 10 to 
10 of 10 pigs tested. Of the total 433 pig sera examined, 291 
had antibody titers (67.2 per cent). 
There were slaughter data available on 169 of the pigs tested. 
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Table 1. Results of IHA tests on sera from experimentally 
infected pigs 
Serologic With Without 
Group Results Lesion Lesion 
I 
Positive 19/20" 1/4** 
Negative 1/20 3/4 
Positive 15/16 0/4*** 
II 
Negative 1/16 4/4 
Positive 23/26 2/4** 
III 
Negative 3/26 2/4 
*Number of pigs reacting to serologic test over number 
of pigs with lesions. 
Number of pigs reacting to serologic test over number 
of pigs without lesions. 
***Ùn-infected control pigs. 
Eighty seven(51.5 per cent)of the pigs had macroscopic pneumonia 
as against 82 with grossly normal lungs. Antibodies were detected 
in 78.1 per cent of the pigs with macroscopic lung lesions and in 
68.2 per cent of the pigs without macroscopic lesions. The data on 
six SPF herds are presented in Table 2. 
Duration of passively transferred antibodies 
Both F and G vaccine derived antibodies reached maximum level 
six hours after they were passively transferred. The former re­
mained at that level for about eight days then started to fall 
whereas the litter remained for 30 to 40 days. The vaccine F 
derived antibodies decreased to an insignificant level 18 to 25 days 
Table 2. Mycoplasma hyopneumoniae antibodies in Iowa SPF herds as compared with lung lesions 
Sam­
ple Herd I Herd II Herd III Herd IV Herd V Herd VI 
no. IHA Lesion IHA Lesion IHA Lesion IHA Lesion IHA Lesion IHA Les ion 
1 256 NA* 32 ** 2 4 S 3 - f 256 + 
2 256 32 sÂ^ 2 *» — 4 » — 6 128 - -
3 256 — — 4 NA 32 — — 256 3 256 — 
4 256 - - 8 - - 8 NA 4 3 256 NA 
5 256 - - 2 S 32 - - 32 - 3 — 128 - -
6 64 - - 2 NA 32 + 8 S 48 — 64 S 
7 128 + 16 NA 8 + 4 + 12 16 — 
8 128 - - 2 16 — 16 + 3 64 — 
9 128 — — 16 — — 16 — — 64 — — 3 — 64 — — 
10 64 — — 2 — — 16 — — 8 — — 6 64 — — 
*Not available. 
Negative gross lung lesion, 
^positive lung lesion. 
f^Scarring in the lung. 
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after they were transferred as against 30 to 50 days for the vaccine 
G derived antibodies. The duration of passively transferred F and 
G antibodies are presented in Figures 3 and 4, respectively. 
Specificity of Indirect hemagglutination test 
There was no serological reaction when Antigen II was tested 
against antisera to M. granularum or M. hyorhinis. Furthermore, 
there was no observable reaction when the latter two organisms made 
into IHA antigens with the procedures were used to make Antigen II and 
were tested against M. hyopneumoniae sera. 
Serological reaction of Mycoplasma hyopneumoniae Antigen II 
with Erysipelothrix insidiosa antisera was observed at low level 
(Figure 5). 
Excellent correlation was obtained between indirect hemagglutina­
tion and previously reported complement-fixation results. The re­
sults of the comparison are presented in Table 3. The complement-
fixation data were obtained from Takatori jet (1968) . 
Treatment of pig sera with 2-mercaptoethanol 
The titer of sera from experimentally infected and from hyper-
immunized pigs, after treatment with 2-mercaptoethanol, generally 
decreased by two-fold. Most of the serologically positive sera from 
SPF pigs were completely devoid of antibody titer after treatment. 
A few decreased in titer by only four-fold. 
Figure 3. Fate of passively transferred Ab-F-ab 
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Figure 5. Indirect hemagglutination patterns 
From top row to bottom row 
Row 1: preinoculation serum 
Row 2: 120 day post-inoculâtion serum 
Row 3: hyperimmune pig serum 
Row 4; Erysipelas antiserum rabbit origin 
Row 5: Erysipelas antiserum horse origin 
Row 6; diluent control 
Two-fold dilution starting from 1:3 utilizing 
Antigen II. 
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1 32 192 2 2 64 256 
2 128 96 2 2 16 256 
3 32 192 2 2 4 256 
4 256 384 2 2 32 256 
5 64 384 2 2 4 256 
6 128 96 2 2 256 236 
7 64 192 2 2 128 256 
fa 64 • 192 2 2 16 32 
9 32 2 2 64 32 
10 32 NS' ' 2 2 64 64 
11 — — 2 2 
12 — — — — 2 2 — — — 
''CF results from Takatori £l. 1968• 
**No sample remaining. 
Preservation of red blood cells 
Method A All cells, antigen treated and control cells, were 
lysed when they were thawed several minutes after freezing. 
Method B Ninty-five per cent of the cells were lysed when 
thawed one week after freezing; 100 per cent lysis was observed in 
those thawed the second week. 
Since neither of the preservation methods was satisfactory for 
swine red blood cells, attempts to preserve antigen coated cells 
were abandoned. 
Agar-gel diffusion 
Antigen I was found to be better than the other two antigen 
preparations for this purpose since it gave more intense precipitin 
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lines. It was therefore used for the test. 
Sera from pigs hyperimmunized with vaccines A, F and G each 
gave two distinct and one faint bands in gel diffusion. Pre-inocula-
tion sera did not react with Antigen I in the gel diffusion system. 
The precipitin antibodies started to appear seven days after the 
first vaccination. The intensity of the precipitin lines increased 
as the days after immunization increased. There was no precipita­
tion reaction when experimentally infected and naturally infected 
pig sera were used. 
Immunoelectrophoresis 
No precipitation reaction was observed when infected lung 
homogenate was used as the antigen. A faint precipitin line was found 
in the IgG region when Antigen I was pipetted into the center trough 
and run against sera from F and G vaccine inoculated pigs after the 
serum had already undergone electrophoresis. There was no reaction 
between antigen I and pre-infection and 12 week post-infection sera. 
Metabolic Inhibition test 
No metabolic inhibition of Mycoplasma hyopneumoniae by infected 
pigs sera or hyperimmune sera was observed in the system utilized. 
Isolation of Mycoplasma hyopneumoniae 
Isolation of M. hyopneumoniae from experimentally infected pigs 
was achieved consistently. None of the negative control pig lungs 
yielded M. hyopneumoniae. None of the attempts to isolate mycoplasma 
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from lesionless lungs of pigs that had been vaccinated and then 
infected were successful. Organisms were recovered from pigs that 
had been immunized and infected but developed lesions. 
Stability of antigen 
Antigen preparation was stable at 4 C for more than two months. 
Animal Infection 
Inoculation of pigs 
Pigs inoculated intranasally with M. hyponeumoniae evidenced 
some mild coughing two weeks after infection. No other clinical 
signs were observed. On necropsy, there were no gross lesions 
except in the respiratory tract. The trachea contained mucous 
that was occasionally blood tinged. The lungs of the infected pigs 
had purple to gray colored, well demarcated lesions in the apical, 
cardiac and sometimes in the intermediate lobes. 
Negative control pigs receiving no inoculations all had grossly 
normal lungs. 
Microscopic lesions 
Experimentally infected pigs The lung tissue was edematous 
and hemorrhagic. The hemorrhage is believed to be due to electrocu­
tion. Extensive lymphoid infiltration and/or hyperplasia were present 
around the bronchioles and blood vessels. Moderate numbers of lymphoid 
cells, neutrophils, and eosinophils were present in the interstitial 
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region. The lumen of some of the bronchioles was slightly con­
stricted due to the hyperplasia of lymphoid cells and sometimes 
contained septal cells, neutrophils, and cell debris. Fibrosis of 
the interstitial area was observed in a few cases (Figure 6). 
Immunized pigs with no lesions A few lymphoid cells were 
observed in the peribronchiolar regions; hemorrhage was noticeable. 
The lungs were slightly emphysematous (Figure 7). No other lesions 
were noticeable. 
Immunized pigs with lesions Massive lymphoid infiltration 
was present in the peribronchiolar areas and resulted in the stenosis 
or complete blockage of air passages. Areas of necrosis were also 
seen. Extensive fibrosis was present in the interstitial and peri­
lobular regions. Alveoli were collapsed. 
The pathological lesions of pigs passively immunized then infected 
were similar to those in actively immunized then infected pigs. 
Formalinized bacterin immunized pigs All four pigs inoculated 
with vaccine H, had more extensive gross lesions than the infected 
controls. Affected lobules of the lungs were edematous and had a 
more severe lymphoid and neutrophilic infiltration in both the peri­
vascular and peribronchiolar areas. Secretory glands in the bronchi 
were significantly increased. The lumen of the bronchi were filled 
with lymphocytes, neutrophils, septal cells and cell debris. There 
was an increased amount of fibrous tissue in the interlobular septum. 
(Figure 8). 
Figure 6. Peribronchiolar lymphoid hyperplasia 
observed in experimentally infected pig. 
XlOO H and E stain 
Figure 7. Microscopic lesion of an immunized then challenged 
pig with no gross lesion. Moderate cellular response 
in peribronchiolar region. The lung was slightly 
emphysematous. XlOO H and E stain 

Figure 8. Formaiinized bacterin administered intranasally 
(vaccine H). The pig had extensive gross lesions. 
Massive lymphoid infiltration, and septal cell 
proliferation, XlOO H and E stain 
Figure 9. Tissue from pig that was infected then inoculated 
with vaccine B. Nodular proliferation of lymphoid 
cells is apparent. Mitotic figures are present in 
many areas. XlOO H and E stain 
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. Infected then immunized pigs Distinct hyperplastic 
lymphoid nodules were present (Figure 9) throughout the lobules. 
In some instances, the lymphoid cells invaded into the bronchi. 
Mitotic figures were frequently observed in the lymphoid cells. 
Interstitial areas were edematous and contained hemorrhage. 
Active Immunization 
Experiment 1 
None of the four vaccinated pigs had gross lesions whereas 
four out of four positive control pigs developed lesions of 
mycoplasmal pneumonia. 
Experiment II 
Three of four vaccinated pigs were grossly normal while the 
remaining one had pneumonia. All four positive control pigs had 
extensive pneumonia. 
Experiment III 
One of the three inoculated then immunized pigs developed 
lesions. One of the remaining two had scars in the lung while the 
other animal had no pneumonic lesions. 
Experiment IV 
Two of the four vaccinated pigs had no lesions while three 
out of four positive controls had pneumonia. 
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Experiment V 
Four out of four vaccinated pigs developed lesions as did 
the four positive controls. 
Experiment VI 
One out of four vaccinated pigs was protected from pneumonia. 
Four out of four positive controls were infected. 
Experiment VII 
Three out of three pigs receiving vaccine C and three out of 
three pigs receiving vaccine D developed pneumonia. Three out of 
three positive control pigs also had pneumonia. None of the three 
pigs that received vaccine D and were then put in close contact 
with infected pigs had pneumonic lesions. 
Experiment VIII 
Two of the pigs that received vaccine E died during the course 
of immunization. One of the two surviving vaccinated pigs developed 
pneumonic lesions upon challenge; the remaining pig's lung was 
grossly normal. 
Three out of four pigs that received vaccine F had lungs that 




Six out of eight pigs immunized with vaccine F, and two out of 
three pigs immunized with vaccine G were protected from mycoplasma 
pneumonia. All of the four positive control pigs were infected. 
Experiment X 
None of the four pigs receiving formalinized bacterin intra-
nasally were protected from infection. On the contrary, these four 
pigs had more extensive lesions than the four positive control 
pigs. 
Experiment XI 
Five negative control pigs were necropsied prior to challenge 
of the remainder and all five had grossly normal lungs. Ten out of 
14 pigs receiving vaccine F and 13 out of 13 pigs receiving vaccine 
G were protected from mycoplasmal pneumonia. Eleven out of 15 
positive controls developed pneumonia following challenge. 
The results of active immunization trials were summarized in 
Tables 4 and 6. 
Passive Immunization 
Experiment I^ 
Antiserum collected from Experiment I (vaccine A) described 
in the Active Immunization results was passively transferred to 
pigs. It protected two out of five pigs from mycoplasmal pneumonia. 
Table 4. Active immunization of 
hyopneumoniae 










I A 0/4 4/4 
II B 1/4 4/4 
IV B 2/4 3/4 
V G 4/4 4/4 






















''Number of pigs that had pneumonia over tlie number oC pigs in trial. 
''^Contact challenge exposure, 
''**Two of the pigs died during the experiment-
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All five non-immunized positive controls became infected. 
Experiment II 
One of three pigs receiving antisera from F vaccine immunized 
pigs was protected from mycoplasmal pneumonia. Both positive 
control pigs developed disease. 
Experiment III 
Two out of two positive control pigs became infected whereas 
all four pigs receiving antisera from G vaccine immunized pigs were 
protected from mycoplasmal pneumonia. 
Experiment IV 
Nine out of 10 immunized pigs were protected from mycoplasmal 
pneumonia while 11 out of 15 pigs became infected. The protected 
pigs received antisera from the same source as was used in Experi­
ment III. 
The results of the passive immunization trials are summarized 
in Tables 5 and 6. 
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Table 5. Results of passive immunization trials 
Passive Contro1 
Expt. immunized pigs pigs 
nc;. infected* infected 
I 3/5 5/5 




IV 1/10 11/15 
"Number of pigs that had pneumonia over number of pigs in trial. 
'''^Contact challenge exposure. 
Table 6. Statistical analysis of results of immunization trials 
Active Immunization Passive Immunization 
9 Antibody derived 
Vaccine •X Value from vaccine Çf^value 
A 
ii 4.2 A 1 . 2  
C ] .05 F 0.83 
D 0.0 G 16. 
E 2.4 
F 15.8 
C 14.3 • 
'^'significant at 0.025 piur cent level. 
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DISCUSSION 
The indirect hemagglutination test described by Dowdle and Robinson 
(1964) was first utilized in the present study for the attempted 
detection of antibodies against M. hyopneumoniae without much success. 
This method detected a low level of antibodies in serum from an 
infected pig. This serum from an infected pig hemolyzed the sheep 
rbc utilized for the IHA test. Since the hemolysis impaired the 
indirect hemagglutination reaction, and since the sensitivity of the 
test procedure was low, it was decided to use swine rbc as the carrier 
and to modify the preparation of antigens. Goodwin et. âl* (1969) 
reported that an IHA test with intact M. hyopneumoniae utilizing 
sheep rbc as carrier could yield IHA antibody titers of higher than 
1:40,000. In the early stage of the present study, the intact 
mycoplasma attached to sheep rbc had been used as the antigen for the 
IHA test, however, it was abandoned as no indirect hemagglutination 
reaction was observed. 
The indirect hemagglutination test developed for the detection 
of antibodies against M. hyopneumoniae was capable of detecting anti­
bodies 14 to 21 days after exposure. The antibodies persisted for 
more than 320 days in swine. Goodwin et_ al.. (1969) with their method, 
found no detectable antibody for three to four weeks post-infection, 
yet obtained high antibody titers in pigs infected four months 
previously. 
Antibody response in pigs exposed by contact infection showed 
variation. Pigs in contact with infected pigs on the day of infection 
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produced antibody earlier than those that were in contact with pigs 
that had been infected two months previously. These previously 
infected pigs had antibody titers of 1:192 or higher. The efficiency 
of transmission of this disease was probably decreased by the develop­
ment of an adequate antibody titers as no lesions were found in 
pigs that were put in contact with them. It is possible that anti­
body produced in the pigs was in some way capable of decreasing the 
virulence or quantity of mycoplasma transmitted. 
It was found that in hyperimmunized pigs, two inoculations 
produced the maximum antibody titer and the third inoculation did 
not further increase the antibody titer. This finding is in agree­
ment with the observation made by Goodwin et £l. (1969) who found 
that in immune pigs, further challenge would not increase IHA or 
CF antibody titers. All of the parenterally vaccinated pigs in 
this present study, had antibody titers of 1:3,072 or higher yet only 
48 out of 75 (64 per cent) pigs were protected from pneumonia. It 
is possible that the antibody measured by indirect hemagglutination 
is not completely associated with protection. It is also probable 
that the challenge dose of organisms was much greater than any 
likely to be encountered in the usual swine production system. 
When the antibody elicited by vaccine G were passively trans­
ferred to healthy pigs, it protected the pigs from pneumonia 13 out 
of 14 times. The possible explanation may be that the vaccine im­
munized pigs were exposed two weeks after receiving the last dose 
of vaccine and there was not time enough for protection to attain an 
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optimal level. The protective antibody may require a longer time 
to reach a significant level, and therefore, when the antisera was 
obtained five weeks after immunization or three weeks after chal­
lenge, it passively conferred immunity. If this is correct, it 
should be possible to challenge pigs four to five weeks after im­
munization and obtain better protection than was obtained in the 
present trials. Further studies are necessary to answer this question. 
Since the passively transferred antibody conferred immunity in 
pigs, it is probable that the protective mechanism is a circulating 
antibody instead of local immunity. The finding that circulating 
antibody is the protective mechanism in swine pneumonia is different 
from the observation made on contagious bovine pleuropneumonia. Lloyd 
(1967) reported that immunity could not be transferred by using anti-
sera obtained from cattle. But Smith (1967) by using mice as a 
model, was able to demonstrate the suppression of bacteriemia by 
passively transferred antibody from recovered mice. Davies and Hud­
son (1968) demonstrated that growth inhibiting antibody in cattle 
was not associated with immunity and concluded that resistance to 
CBPP did not involve circulating antibody but was probably due to 
some form of cell mediated immunity. Since Smith was using mice as 
the experimental animal, and the other workers were using cattle, 
the conflicting results could be due to the differences in animal 
models. 
Antibodies derived from pigs receiving vaccine G, when passively 
transferred, remained at a detectable level in pigs for 51 days as 
compared with 31 days for passively transferred antibodies derived 
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from pigs vaccinated with F vaccine. The F vaccine stimulated anti­
body protected fewer pigs from pneumonia than did the G vaccine 
stimulated antibody. This indicates that it is some property of 
antibody other than IHA titer alone that is responsible for protec­
tion. Both F and G vaccines gave about the same percentage of pro­
tection in actively immunized pigs, yet only antibody from pigs 
receiving G vaccine conferred a significant degree of protection when 
it was passively transferred. 
The duration of protection in those passively immunized pigs 
and the ability of the protective antibody to pass via colostrum to 
confer protection to new born pigs was not determined. 
Goodwin et al^. (1969) observed a non-specific antibody titer 
in one of their experimental pigs. They did not indicate the origin 
of the antibody. In the course of the present study, sera from two 
litter-mates were found to have antibody titers before infection. 
The antibody, however, was removed by 2-mercaptoethanol treatment, 
and was therefore believed to be a 19s antibody. Treatment by 2-
mercaptoethanol decrease antibody titers of sera from infected and 
hyperimmunized pigs by two-fold. This indicated that the antibody 
in sera from infected and hyperimmunized pigs was not extremely 
sensitive to 2-mercaptoethanol and that it probably was a 7s im­
munoglobulin. The finding that mycoplasmal pneumonia antibodies 
produced in pigs is a 7s immunoglobulin is in agreement with the find­
ings of Lynn (1967) who found antibody produced in rabbits to S-2 
strain of swine mycoplasma was associated with 7s immunoglobulin. 
Schmidt et al. (1966) reported that in human atypical pneumonia, 
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the CF antibody was entirely or in the major part 19s immunoglobulin 
based on various methods of separation and characterization including 
2-mercaptoethanol treatment. However, Fernald aj^. (1967 a and b) 
noted that 2-mercaptoethanol treatment only partially reduced CF 
titers against M. pneumoniae in early convalescent sera but had no 
effect on later sera. They suggested that a transition to 2-
mercaptoethanol-resistant antibody or 7s immunoglobulin had occurred. 
The human sera used by the former workers were from patients showing 
significant increase in CF antibody suggesting convalescent. The 
latter workers were using .hamster sera. The conflicting results 
between these two groups of workers were not resolved. Investiga­
tion of the possible occurrence of'the sequential antibody transi­
tion observed by Fernald, is needed in ^  hyopneumoniae pneumonia. 
Fernald et al^. (1967 a and b) also noted that IHA antibody of 
human and rabbit origin to M. pneumoniae was destroyed by 2-mer­
captoethanol and suggested that it was a 19s immunoglobulin. This 
finding is different from our observation in swine which indicated 
the IHA antibody is a 7s immunoglobulin. 
The limited amount of comparative work between CF and IHA tests 
revealed an excellent correlation. Hodges and Betts (1969), using the 
CF test, reported that in infected herds, antibodies were detected 
in 81 per cent of those pigs with macroscopic lesions of pneumonia 
and in 69 per cent of pigs without macroscopic lesions. They also 
found antibodies to M. hyopneumoniae in 61 per cent of bacon pigs 
with macroscopic pneumonia and 12 per cent of animals without macro­
scopic lesion. The present study showed that 87 out of 169 pigs with 
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lung data available had macroscopic lesions of pneumonia (51.5 per 
cent). Antibodies were detected in 78.1 per cent of the pigs with 
macroscopic lesions and in 68.2 per cent of the pigs without macro­
scopic lesions. The present results and those reported by Hodges and 
Betts (1969) indicated that there is some correlation between 
pneumonic lesions and antibody titers. This data also shows that a 
high per centage of the lesionless pigs had antibody titers to M. 
hyopneumoniae. This poses a severe problem in evaluation of lesion-
less swine as false positive reactors or as lesionless carriers. 
The lack of absolute correlation between antibody titer and 
gross pneumonic lesions in field samples could be due to various 
reasons. First of all, the serologic tests, i. e., IHA or CF test, 
might not be reliable; second, there may be organisms other than myco­
plasma that are capable of producing the same gross pneumonic lesions; 
and third, there may be other organisms that share antigens with M. 
hyopneumonia. 
Good correlation between CF and IHA tests, no cross-reaction 
among M. hyopneumoniae, M. granularum, and M. hyorhinis as detected 
by CF and IHA tests, and no cross-reactions between swine influenza 
and Mycoplasma hyopneumoniae (Takatori et al. 1968) indicate the 
specificity of the serologic tests utilized for the detection of anti­
bodies against M. hyopneumoniae. In addition, the evidence that the 
IHA could detect antibody in 95 per cent of experimentally infected 
pigs supported the notion that the IHA test is specific for the de­
tection of antibodies against M. hyopneumoniae in pigs. 
Jericho (1968) warned that some features of pneumonia were 
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common to more than one pneumonic conditions and could not be used 
as the basis for definition of a specific pneumonia. Proliferation 
of intraplumonary lymphoid tissue and alveolar septal cells probably 
constitute this type of lesions and should not be unduly relied upon 
for the recognition of swine mycoplasmal pneumonia. The author listed 
similar histopathological lesions caused by M. hyopneumonie (Mare 
and Switzer, 1965), human adenovirus (Jennings and "Betts 1962), animal 
enterovirus (Meyer et. 1966) and influenza virus (Nayak £t al. 
1965), and cautioned against using one specific gross or pathologic 
lesion for a definitive diagnosis of a pneumonic condition. Since 
many organisms can cause lesions resembling mycoplasmal pneumonia, 
it may explain some of the lack of correlation between the gross 
pneumonia and the IHA serologic results. 
The finding that erysipelas antiserum cross reacted with M. 
hyopneumoniae may also account for the lack of correlation. Antigen 
II coated swine rbc had reacted with Erysipelothrix insidiosa anti­
serum made by hyperimmunizing rabbits or horses. Post-infection 
serum from M. hyopneumoniae infected pig also reacted with E. in­
sidiosa coated swine rbc used as the IHA antigen. The finding poses 
a problem in the application of the IHA test to field swine. 
The antigen preparations used for the IHA test could be stored 
at 4 C for up to two months without losing any antigenicity, however, 
the swine rbc preparation required frequent laborious washings and 
tanning procedures. Therefore, attempts were made to preserve.the 
antigen-coated rbc by freezing. Neither of the two methods of preser­
vation attempted was successful. The excessive hemolysis of swine 
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rbc may be due to the unusual fragility of swine red blood cells. 
Swine rbc were used because of the presence of a natural 
hemolysin in swine sera to sheep rbc. The hemolysin was heat stable 
and was difficult to absorb from swine sera. In addition, the hemo­
lysin was present in minimal amount in young pig, and increased in 
potency as the pig aged. Since most field samples tested were from 
pigs five months of age or older, the hemolysin titers were high. 
This hemolytic effect masked the antigen-antibody reaction. The 
swine rbc was not as good an antigen carrier as sheep rbc which 
generally gave one to two-fold higher titers in the test. This dis­
advantage was offset by the detection of low levels of antibody 
activity by the swine rbc antigen carrier system. 
Lysis of organisms by SLS was very effective. Cloudy suspens­
ions of mycoplasma were cleared in a few minutes. Most of the SLS 
was removed in the first change of buffer solution. Engleman and Horo­
witz (1968) reported that after 36 hours of dialysis against three 
changes of buffer solution, the dialyzate contained only 1.7 per cent 
of the initial amount of SLS as determined by radioactivity counts. 
The aggregated dialyzate was then forcefully resuspended and 
treated with merthiolate. The original purpose of adding the mer­
thiolate was to prevent contaminants from growing (Rodwell e^ al. 
1967) while the antigen was stored at 4 C, but later it was found 
that the merthiolate addition, was essential for the demonstration 
of antigen-antibody activity in the IHA test. Fresh antigen devoid 
of merthiolate failed to react with antiserum whereas the same antigen 
preparation with merthiolate added at a 1:10,000 final concentration 
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was capable of detecting antibody. Also, the addition of merthio-
late helped prevent the re-aggregation and precipitation of the 
antigen during storage at 4 C. The role of merthiolate in binding 
antigen to the carrier rbc was an unexpected finding that deserves 
further exploration, 
Lannek and Bornfors (1957) showed that a strong immunity 
developed in pigs experimentally infected with enzootic pneumonia 
even though Betts et al. (1955) found no evidence of any appreciable 
degree of immunity in pigs that were naturally infected by myco­
plasmal pneumonia. Lannek and Bornfors (1957) infected a group of 
pigs and allowed them to recover and then challenged them four months 
after primary infection. They found all the re-infected pigs were 
free from enzootic pneumonia, whereas all the positive controls had 
pneumonia. The authors did not demonstrate neutralizing antibody 
in those re-infected pigs. Goodwin et al. (1969) found that pigs 
recovered from the disease were strongly resistant to challenge. 
The pigs developed virtually no lung lesions when infected with viru­
lent inoculum that produced extensive lesions of enzootic pneumonia 
in control pigs. 
The results of these workers are very difficult to interpret 
because the conditions necessary to insure the recovery of pigs 
from mycoplasmal pneumonia were not specified. In the present study 
two out of three swine still had pneumonia 11 months after infection. 
The commercial SEP vaccine* produced and marketed for a short 
time in Sweden is the only known vaccine utilized for the prevention 
*Chas. Pfizer, Inc., Sweden 
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of mycoplasmal pneumonia in swine. The vaccine contains formalinized 
M. hyorhinis the causative agent of a polyserositis and arthritis 
in swine. This mycoplasma is a frequent secondary invader of swine 
pneumonia (L'Ecuyer, 1962). According to available informa­
tion, 10,000 doses of the SEP vaccine (Pfizer, Inc., 1968) were 
used from 1962 to 1968 in several herds of pigs. Some previously 
severely infected herds, through a systematic vaccination program, 
were able to bring the pneumonia under control. Since M. hyorhinis 
is serologically distinct from M. hyopneumoniae (Switzer, 1969), 
the established etiological agent of mycoplasmal pneumonia or swine 
enzootic pneumonia, the use of a M. hyorhinis vaccine for the preven­
tion of mycoplasmal pneumonia is difficult to understand. 
The vaccine preparations used in the present study contained 
M. hyponeumoniae. Vaccine H contained formalinized organisms. The 
rest of the preparations were made from lysed organisms or components 
of M. hyopneumoniae. The preliminary results obtained in the present 
study by the use of M. hyopneumoniae for immunization against this 
disease indicates considerable potential for this procedure to aid in 
the control of this particular swine pneumonia. Both F and G vaccines 
used in the present study protected about 80 per cent of the immunized 
pigs from pneumonia. 
Smith (1969) reported that a large, single dose of inactivated 
CBPP vaccine given intravenously conferred virtually complete protec­
tion against a wide range of challenge in mice, while subcutaneous 
vaccination failed to produce even slight immunity. Vaccine prepara­
tions A through G in the present study were all administered 
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intramuscularly with incomplete Freund adjuvant. Vaccine H 
(formalinized bacterin) was administered intranasally and failed 
to protect pigs from infection, in fact, the vaccinated pigs developed 
more extensive lesions than the infected control pigs. Since 
vaccine H was not administered intramuscularly, it is not possible 
to compare this product with other vaccines. Additional study is 
required to determine the most effective antigen preparation and 
administration for the control of the disease. 
The failure of vaccines F and G to give complete protection 
may be due to inadequate dosage or to inadequate immunogenic material 
present in the vaccines. The yield of M. hyopneumoniae, with present 
technique, is still meager, and it is hoped that a better growth 
medium will eventually become available for the more abundant growth 
of the organism so that it can be more readily studied and utilized 
in antigen-antibody reactions and in vaccine production. 
There were small local abscesses formed as the result of adminis­
tration of F vaccine. The abscess formation may have been due to 
contamination of the vaccine since only blood agar plates were used 
for sterility check. The abscess may also have resulted from the 
action of the adjuvant. Further effort can probably eliminate this 
problem. 
Cattle vaccinated with the Ti strain of broth vaccine against 
CBPP were found to have persistent mycoplasma in the body. It was 
suggested that the survival of viable organisms in the body was 
correlated with a positive complement fixation test (Davies, 1969). 
Fernald (1969) was able to isolate Mycoplasma pneumoniae from 
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immunized and infected hamster lung tissues. He could infect and 
produce pneumonia in all control animals and in all animals vac­
cinated parenterally. In previously infected and recovered animals, 
however, complete protection from pneumonia was observed. The 
frequency of mycoplasma isolation was significantly less (55 per 
cent) than in the non-immunized, infected controls. Thus a 
previous respiratory infection with M. pneumoniae produced partial 
resistance to re-infection and complete protection against develop­
ment of pneumonia. 
In the present study, attempts to isolate M. hyponeumoniae from 
lesionless lungs of pigs that had been vaccinated and then chal­
lenged were unsuccessful. Organisms were isolated from pigs that 
had been immunized and infected but developed lesions. This evidence 
indicates that the immunized, lesionless pigs harbor no recoverable 
organisms and should not constitute a reservoir of infection. 
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SUMMARY 
An indirect hemagglutination (IHA) test for the detection of 
Mycoplasma hyopneumoniae infection has been developed. Pigs infected 
with the agent developed antibodies two to three weeks post-infection. 
The antibody titer reached its peak on the 63rd day of infection, 
and remained at that level for 130 days. The level of antibody 
started to fall off gradually after that, but remained detectable 
for at least 320 days post-infection. 
Healthy pigs in contact with pigs that had just been infected 
with live culture of M. hyopneumoniae developed antibody titer in 
five to six weeks. When susceptible pigs were in contact with pigs 
that had been infected two months previously, the susceptible pigs 
developed antibody in seven to eight weeks but failed to develop lung 
lesions. This indicates that adequate neutralizing antibody to 
retard the transmission of the disease was produced after a period 
of infection. 
Four hundred thirty three swine serum samples from various 
field herds were tested for antibodies against M. hyopneumoniae. 
Two hundred ninety one of them were serologically positive (67.2 
per cent). There were slaughter data available on 169 of those 
pigs. Eighty seven (51.5 per cent) of the pigs had lungs that were 
pneumonic as against 82 that had grossly normal lungs. Anti­
bodies were detected in 78.1 per cent of the pigs with macroscopic 
lung lesions and in 69 per cent of the pigs without lesions. 
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Eight vaccine preparations were evaluated in this study for 
their ability to prevent pneumonia. Vaccines F and G were both 
found to protect about 80 per cent of pigs from pneumonia. Anti­
body levels were found to differ by only a two-fold dilution in 
all of the vaccinated pigs, yet some were protected from pneumonia 
while others were not. Therefore, it appears that IHA antibody 
level in vaccinated pigs may not be completely associated with 
protection. 
Serum from pi,gs receiving vaccine F, when passively transferred, 
protected one out of three pigs from pneumonia; serum from pigs 
receiving vaccine'G conferred immunity against pneumonia to 11 out 
of 12 pigs. 
No Mycoplasma hyopneumoniae was recovered from the lungs of 
pigs that were protected from pneumonia by either active or passive 
immunization. 
The sera from experimentally infected and from vaccinated 
pigs were partially resistant to 2-mercaptoethanol treatment. The 
antibody were therefore thought to be a 7s immunoglobulin. 
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